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ABSTRACT
PREVOTELLA PHYLOGENY: GENOMIC AND MOLECULAR INSIGHTS INTO THE ROLE OF
THE HUMAN COMMENSAL PREVOTELLA IN CYSTIC FIBROSIS
Prioty Ferheen Sarwar
Paul Joseph Planet
The genus Prevotella comprises of a diverse set of gram-negative anaerobes that are implicated
in both health and disease. Prevotella is a common human commensal of various anatomic sites,
but it can also be associated with the dysbiotic microbiomes of various chronic inflammatory
diseases. Due to its association with both commensalism and disease, the role of Prevotella in
disease progression is unclear. However, Prevotella has shown immunomodulatory potential, the
ability to change the metabolic microenvironment and other cytotoxic phenotypes in both in vitro
and in vivo studies. Despite this, Prevotella remains understudied both at the genomic and
phenotypic levels. In this thesis, I explore the role of Prevotella in the context of the cystic fibrosis
lung microbiome. I characterize the ecological composition of a longitudinal pediatric CF cohort
called EcoCF and show that the prevalence and relative abundance of Prevotella remains relatively
stable from mild to severe lung disease. Prevotella is often the dominant genus in samples of
higher bacterial diversity, which is associated with higher lung function but Prevotella is also
differentially enriched in samples of lower lung function, where bacterial diversity is low. I attempt
to explain this contradictory result by exploring the genomic diversity in the genus Prevotella, with
a focus on P. melaninogenica and its closely related species that are often associated with the CF
lung. We show that P. melaninogenica is a complex of species with varied potential for horizontal
gene transfer. Prevotella species have high recombination rates but also complex restrictionmodification systems.

Our work highlights the large genomic diversity within some of the

oropharyngeal commensal Prevotella, indicating that the key to drawing meaningful associations
of Prevotella with health and disease is by studying the genus Prevotella resolved at the strainlevel.
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CHAPTER 1: INTRODUCTION

Advances in sequencing technology have brought us into an era of cultivation-free
microbial profiling, which helps us uncover the complexity of the human microbiome as it relates
to health and disease. This new technology has moved us beyond the narrative of the typical
disease-causing pathogen, as defined under Koch’s postulates, into exploring disease in the
context of complex polymicrobial networks and their unique interactions with the host. We are
now able to truly appreciate the role that commensal bacteria – that is, bacteria that have evolved
alongside humans to have mutualistic (neutral or symbiotic) relationships with them -- play in
maintaining a healthy state or exacerbating disease in stressed or altered micro-environments.
Frequent interactions of commensals with the host immune system can, depending on
the context, prime the immune system for an overall more protective and robust immune
response or drive the microenvironment towards a chronic inflammatory state (Hooper & Gordon,
2001; Martens et al., 2018; Zheng et al., n.d.). In addition to affecting health and disease
indirectly by inflammatory modulation and contributing to mucosal barrier development and
nutritional uptake in the host, several bacteria straddle the duality between asymptomatic
commensal and disease-causing opportunistic pathogen like Escherichia coli, Group B
Streptococcus, Staphylococcus epidermis etc (Armistead et al., 2019; Brannon & Mulvey, 2019;
Brown & Horswill, 2020; Leimbach et al., 2013). The focus of my thesis is the genus Prevotella,
consisting of gram-negative anaerobes, which occupies this space of well-established
commensalism with humans and a potential negative effect on health in the context of microbial
dysbiosis.
Prevotella has strong ties to both improved gut health and an established proinflammatory phenotype in the context of periodontal disease (Kovatcheva-Datchary et al., 2015;
Yamashita & Takeshita, 2017). However, we are left with a spectrum of diseases where the role
of the members of Prevotella in disease progression is unclear and highly debated. In this

1

chapter, I will highlight the prevalence and potential role of Prevotella in the context of different
microbiomes, provide an overview of some potential modes of pathogenesis of various Prevotella
species and summarize my dissertation aims. Since my dissertation is centered around
understanding the genomic diversity and potential pathogenic role of Prevotella in the context of
cystic fibrosis (CF), I will also summarize the effect of increased bacterial burden and frequent
bacterial infections in the lungs on CF disease progression.

1.1 The prevalence of the genus Prevotella in various microbiomes
The genus Prevotella comprises of 56 identified species of gram-negative anaerobes and is a
ubiquitous part of the human microbiome, found to be present in over 90% of human
metagenomic samples (Tett et al., 2021). Prevotella was emancipated from the genus
Bacteroides in 1990 by Shah and Collins who proposed it as a distinct group of species based on
its biochemical properties and ribosomal RNA identity. At the time, the set of species that
became Prevotella was a distinctly oral and black pigmented species set within the Bacteroides
genus (Johnson & Harich, 1986; Shah & Collins, 1990b). This early association of Prevotella with
the oral cavity and periodontal disease has focused the investigations in the field to the human
oropharyngeal commensals within the genus. While the clinical importance of Prevotella species
in the gut and urogenital tract has been known (Finegold, 1995), it was not until the advent of
culture-free sequencing that we began to appreciate the prevalence of Prevotella across not just
other human anatomic sites but also in other hosts and in the environment (Tett et al., 2021).
1.1.1 Prevotella in the upper and lower respiratory tract microbiomes

The oral microenvironment is highly diverse and colonized by a plethora of viruses,
protozoa, fungi, archea and bacteria. The complexity of the oral microbiome is confounded by
the distinct surfaces that serve as microbial habitats and the contiguous cavity that leads into the
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rest of the upper and lower respiratory tract (Dickson & Huffnagle, 2015; Segal et al., 2013). This
anatomical set-up leads to a related but ultimately distinct microbiomes, making the delineation of
disease related ecological communities that much more challenging (Wade, 2013; Yangheng
Zhang et al., 2018). Prevotella, like other anaerobes, is a commensal of all sites of the
respiratory tract but is particularly enriched in the more hypoxic niches like the tonsils, throat, and
subgingival plaques (Eren et al., 2014; Segata et al., 2012). Many commensals, including
species of the genus Prevotella, play a role in determining oral health or disease progression.
Furthermore, dysbiosis of the oral microbiome with elevated abundance of Prevotella, amongst
other genera, is also associated with other systematic inflammatory diseases like diabetes,
rheumatoid arthritis and inflammatory bowel disease (Graves et al., 2019; Qi et al., 2021).
Enrichment of anaerobic bacteria within the Prevotella, Veillonella and Fusobacterium
genera in the salivary microbiome has been associated with poorer oral health outcomes like
higher susceptibility to dental caries and periodontitis. The salivary microbiome is seeded from
the various sites of the oral cavity and therefore thought to be generally representative of the oral
microbiome (Takeshita et al., 2009, 2014; Yamashita & Takeshita, 2017). While the composition
of salivary microbiome in health and disease might not change overall at the genus level,
differences in the species composition seem to determine the way that the scale between health
and disease tips. In fact, a large population-based study representing 2,343 adults in Japan
shows that the determinant of oral health outcomes could be narrowed down to two bacterial
networks. The community associated with higher microbial richness and poorer health outcomes
includes two Prevotella: P. histicola and P. melaninogenica (Takeshita et al., 2016; Yamashita &
Takeshita, 2017). Prevotella is also associated with more severe periodontal lesions (Costalonga
& Herzberg, 2014; Yangheng Zhang et al., 2018) and several Prevotella species have been
associated with the chronic inflammatory disease periodontitis like P. denticola, P. intermedia, P.
nigrescens and P. melaninogenica (Stingu et al., 2013; Vuotto et al., 2014; Wade, 2013) although
P. intermedia is the only Prevotella species considered a ‘true’ pathogen within the polymicrobial
environment that collectively determines periodontitis severity (Tatakis & Kumar, 2005).
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The lung microenvironment is characterized by a dynamic but low burden of
microorganisms, largely introduced by micro-aspirations from the oral cavity (Bassis et al., 2015).
The transient and low bacterial burden of the healthy lung microbiome is maintained by a
combination of bacterial immigration from the oral cavity and upper respiratory tract, elimination of
bacteria by frequent clearing of mucus by the lung epithelium and regional growth conditions
which in the healthy lung is not highly permissive (Bassis et al., 2015; Charlson et al., 2011;
Dickson et al., 2017; Yagi et al., 2021). The existence of the lung microbiome has been a highly
debated topic, with early ideas that the lung was essentially a ‘sterile’ environment. Even with the
advent of culture independent studies which showed the presence of bacteria in the lower
respiratory tract, whether it was distinct from the upper airways was unclear (Dickson et al., 2016,
2017). However, careful study design and controls have established a lung microbiome in
healthy individuals that is ultimately distinct but either resembles the low bacterial burden and
distribution of background taxa from saline wash controls or has higher bacterial burdens and
resembles taxa enriched in the upper airway. The subset of samples that resembled the upper
airway is characterized by high levels of anaerobes like Prevotella, Rothia and Veillonella and is
associated with lung inflammation of a Th17 phenotype. In particular, these genera represent a
metabolically distinct consortium positively correlated with levels of multiple Th-17 cytokines such
as IL-1α, IL-1β, IL-6, fractalkine and IL-17, Th-17 type cells, neutrophils and lymphocytes in the
bronchioalveolar lavage (BAL) (Segal et al., 2013, 2016).
This association of the presence of Prevotella and a pro-inflammatory phenotype is
consistent with the frequent association of Prevotella enrichment in pro-inflammatory diseases of
the respiratory tract. While the latter association can be found consistently during diseases
characterized by chronic inflammation in the upper respiratory tract, inflammatory diseases of the
lower respiratory tract do not associate with Prevotella as consistently. The lung microbiome of
asthmatic patients and those with chronic obstructive pulmonary disease (COPD) show an
enrichment of Proteobacteria including pathogenic genera like Haemophilus and Neisseria and
reduction in anaerobic commensals like Prevotella and Veillonella (Hilty et al., 2010; Yagi et al.,
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2021). On the other hand, Prevotella amongst other genera in the Bacteroidetes phylum is
enriched in the CF lung (Cuthbertson et al., 2020) and in the lungs of lung cancer patients where
P. melaninogenica and P. intermedia have been identified as dominant species in the microbiome
(Gomes et al., 2019; Jin et al., 2019).
1.1.2 Prevotella in the lung microbiome of people with CF
CF is a genetic disorder that affects over 70,000 people worldwide. CF is caused by
mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that obstructs
the homeostasis of chloride and bicarbonate ions resulting in a thickened, viscous mucus that is
not easily cleared (Bhagirath et al., 2016; Matsui et al., 1998). This in turn leads to dysbiosis in
the lung microenvironment and progressive pulmonary disease and affects over 70,000 people
worldwide. Bacterial colonization, caused by changes in the lung microenvironment, is a critical
factor in morbidity and mortality for patients with CF and control of the overall bacterial load is an
integral part of the CF treatment regimen (Dickson et al., 2016). In contrast, the microbiota
detected in the healthy lung are largely thought to be a transient population, introduced frequently
from microbial aspiration of the upper airway. The lower respiratory microbial composition of the
healthy lung is similar to that of the upper airways but is 2 to 4 logs lower in biomass (Charlson et
al., 2011; Dickson & Huffnagle, 2015).
The CF microenvironment is hypoxic, with oxygen tensions of 0.1- 1%, allowing for
anaerobic respiration by facultative anaerobes (Su & Hassett, 2012; Worlitzsch et al., 2002) and
growth of obligate anaerobes such as Prevotella and Veillonella. Furthermore, mucus plugging
and fibrotic changes from chronic inflammation lead to decreased airway surface for gas
exchange (Hauser et al., 2014a; Sherrard, Bell, et al., 2016). While facultative anaerobic
bacteria, like Staphylococcus aureus, Pseudomonas aeruginosa, Haemophilus influenzae and
the Burkholderia cepacia complex, are identified as bona fide CF pathogens, high numbers of
obligate anaerobes - including Prevotella - have also been found in the CF lung by both culture
and culture free sequencing techniques (Carmody et al., 2018; Coburn et al., 2015; Layeghifard
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et al., 2019; Mahboubi et al., 2016; Sherrard, Bell, et al., 2016). Anaerobic metabolism in the CF
lung, detected at the onset of pulmonary exacerbations in CF patients, suggests that bacterial
respiration may also contribute to a sustained anaerobic environment (Quinn et al., 2015;
Sherrard, Bell, et al., 2016). Multiple studies suggest that anaerobic bacteria likely persist and
replicate within the CF lung. Culture-independent techniques repeatedly isolate anaerobic
bacteria from the CF lung in numbers greater or equal to that of aerobic bacteria from both
sputum and BAL, where BAL is shown to limit upper airway contamination of samples (Harris et
al., 2007; Jones, 2011; G B Rogers et al., 2006; Zachariah et al., 2018; E T Zemanick et al.,
2010; Edith T Zemanick et al., 2017). Anaerobic bacteria can be cultured from CF sputum
samples at bacterial loads between 105 to 108 CFU/g of sputum, equal or greater than that of P.
aeruginosa. While anaerobic bacteria can also be cultured from induced sputum of healthy
individuals, they are present in significantly higher loads in CF patients (Michael M Tunney et al.,
2008).
One of the most commonly isolated anaerobes in the CF lung is the genus Prevotella by
both culture and culture independent sequencing techniques. In fact, Prevotella is consistently
found as being part of the core CF microbiome across all ages and various stages of disease
(Coburn et al., 2015; Cuthbertson et al., 2020; Fodor et al., 2012a; Gilpin et al., 2017; Edith T
Zemanick et al., 2017). While many species of Prevotella have been associated with and isolated
from the CF lung, perhaps the most frequently reported is the P. melaninogenica species
(Cuthbertson et al., 2020; Field et al., 2010; Gilpin et al., 2017). Despite the frequent association
of Prevotella with the CF lung, its role in cystic fibrosis is still poorly understood— studies have
shown that it can increase neutrophil recruitment to the lungs, which can cause tissue remodeling
and structural damage to the lung (Larsen, 2017; Laval et al., 2016; Terheggen-Lagro et al.,
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2005), while at the same time Prevotella has been associated with a lower inflammation in the CF
lung (Edith T Zemanick et al., 2017).

Fig 1.1 Dysbiosis of the CF lung microbiome.

Adapted from Dickson RP, Huffnagle GB (2015). PLoS Pathog 11(7): e1004923(Dickson &
Huffnagle, 2015)

1.1.3 Prevotella in the gut
The genus Prevotella is found in the gut microbiome at a frequency anywhere from 20–
80% of a population. Prevotella is also generally associated with a diverse microbiome in
individuals from non-Westernized countries, that is, those primarily on high fiber and low fat diets
and living in agrarian societies and/or rural and isolated populations (De Filippis et al., 2016; Ley,
2016a; Tett et al., 2021; Wu et al., 2011). In addition to this association, Prevotella at the genus
level also undergoes expansion in the gut after treatment with supplemented dietary fiber in
healthy individuals, an intervention that has been shown to improve glucose metabolism
(Kovatcheva-Datchary et al., 2015). Prevotella species in the gut is similarly thought to contribute
to the breakdown of dietary fibers and complex polysaccharides (Chan et al., n.d.). The
prevalence of the Prevotella and Bacteroides genera in the gut are often inversely correlated,
which was demonstrated most starkly by the rapid loss of gut diversity and Prevotella abundance
as well as a gain in Bacteroides in individuals immigrating to the US from Thailand. The skew is
compounded in obese individuals and those of second-generation immigrants. This loss of
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diversity to some extent can be associated with the change in diet that occurs in moving from a
South-East Asian country to a Western country (Vangay et al., 2018). Reduced Prevotella in the
gut microbiome has even been linked with the development of bacterial vaginosis, where the
presence of the Prevotella species, P. copri in the gut coincided with its presence in the vaginal
microbiomes of healthy controls (Vasundhara et al., 2021). Despite these frequent associations
with health, Prevotella in the gut microbiome has also been associated with rheumatoid arthritis,
development of hypertension and can also be a driver of systemic immune activation in HIV
patients (Armstrong et al., 2018; Larsen, 2017; J. Li et al., 2017). Furthermore, the role of gut
Prevotella in cardiovascular risk factors have had conflicting reports showing a correlation
between lower cardiovascular risk and both higher (Y. Wang et al., 2016) and lower (Y. Li et al.,
2021) abundance of Prevotella.
These contradictory associations can, however, be better understood when we start
inspecting Prevotella in the gut at the species level. The most frequently found and most studied
Prevotella species in the gut is P. copri. When present P. copri is also often the most dominant
species in the gut resulting in a significant impact on the metabolic environment. Despite its
frequency and abundance as a commensal, the enrichment of P. copri has been shown in the
dysbiotic gut microbiome of multiple disease conditions. P. copri in the gut is associated with a
serum metabolome characterized by the enrichment of branched chain amino acids which drive
the host towards increased insulin resistance and glucose intolerance (Krogh Pedersen et al.,
2016). Despite the prevalence of P. copri in populations eating high fiber diets, a high fiber and
polyphenol rich diet intervention in patients with type 2 diabetes actually decreases the amount of
intestinal P. copri leading to better health outcomes like improved glycemic control and lower
inflammation (Medina-Vera et al., 2019). It was also shown that dietary fiber intervention can
lower plasma levels of C-reactive protein, a biomarker for chronic inflammation, but C-reactive
protein levels were resistant to change in individuals with a high abundance of P. copri in the gut.
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While these studies might give the impression that even species level analysis of the gut
microbiome cannot resolve the role of Prevotella in disease, it is important to note that P. copri
has been recently shown to be a species complex that consists of four distinct clades, each of
which can be classified as its own species when comparing their average nucleotide identities.
Each of the four clades is associated with its own distinct polysaccharide utilization profiles.
Furthermore, P. copri clusters separately based on the diet of the microbiome it has been isolated
from i.e., between omnivorous, vegetarian and vegan diets. It is possible that what really
determines whether P. copri will have a positive or negative affect on health is the metabolic
profile it contributes within the gut microenvironment (De Filippis et al., 2019; Fehlner-Peach et
al., 2019a; Tett et al., 2019). Therefore, meaningful association of Prevotella with diseases relies
both on strain-level analysis and a concurrent effort to identify and characterize those strains at
the genomic level. The goal of such an analysis might be to ultimately characterize the function
and metabolic effect a specific Prevotella strain will have on the gut microenvironment.
1.1.4 Prevotella in the vaginal microbiome
The vaginal microbiome is yet another body site that is in constant flux due to a variety of
reasons that includes but is not limited to sexual activity, menstruation, and chronic stress. The
healthy vaginal microbiome is often characterized by a low bacterial burden thought to be caused
by a low pH microenvironment maintained by the microbial production of lactic acid. A high
abundance of the genus Lactobacillus is perhaps most frequently associated with the healthy
vaginal microbiota. Otherwise, the amount of bacterial diversity and composition of the healthy
vaginal microbiome can differ greatly by geographical and racial differences. Healthy vaginal
microbiomial compositons can also include high bacterial diversity and an abundance of various
anaerobes, including Prevotella. However, this community structure is less stable and prone to
transitioning to a dysbiotic community, which in turn causes bacterial vaginosis (BV). In contrast
to the gut and lung microbiome, where high bacterial diversity is generally associated with better
health, the dysbiotic vaginal microbiome is often characterized by an increase in the bacterial
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diversity and lower amounts of Lactobacillus. Multiple studies have shown that bacterial diversity
and microbial composition of the vaginal microbiome can differ based on racial differences, even
when sampled from the same geographical location. This has led to the hypothesis that
underlying genetic factors that cause a variation in the innate and adaptive immunity might be
shaping the vaginal microbiome, perhaps even more so than behavioral or cultural differences
(Carbonero et al., 2017; Ceccarani et al., 2019; Chee et al., 2020; X. Chen et al., 2021;
Onderdonk et al., 2016a; Zhou et al., 2007).
The vaginal microbiome can also significantly vary between non-pregnant and pregnant
women and a shift in the composition can take place again after pregnancy during the postpartum
period. Healthy pregnancies are often accompanied with an enrichment of Lactobacillus species
and a low bacterial diversity, thought to be the result of a change in the metabolomic landscape
due to the increased production of estrogen by the placenta. The removal of the placenta causes
a sharp decline in the levels of estrogen, resulting in a rise in pH and a microenvironment
permissive for the outgrowth of anaerobes. Taken together with the physiological changes of the
labor and delivery process there is a dramatic shift of the vaginal community composition towards
being highly diverse and anaerobe dominated, Prevotella bivia, being one of the species that is
significantly increase postpartum (Avershina et al., 2017; Nunn et al., 2021).
Prevotella bivia and Gardnerella vaginalis are both considered to be important drivers of
BV pathogenesis. P. bivia is also associated with other uterine pathologies such as preterm birth
and endometriosis (Randis & Ratner, 2019). Surprisingly, neither G. vaginalis nor P. bivia induce
robust inflammatory responses in vaginal epithelial cells of a human or mouse model (Gilbert et
al., 2019; Strömbeck et al., 2007). Instead, it is thought that the primary mode of pathogenesis is
via the formation of a biofilm on the vaginal epithelium initiated by G. vaginalis. Proteolytic
activity by G. vaginalis leads to an environment optimal for P. bivia growth, which in turn produces
ammonia, forming a symbiotic relationship between the two bacteria. P. bivia has also been
shown to alter gene expression of G. vaginalis to promote biofilm formation (Castro et al., 2021).
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Eventually, sialidase production by P. bivia and G. vaginalis breaks down the vaginal mucosa,
resulting in a vaginal epithelium that is vulnerable to injury and increased adherence by other BVassociated bacteria (Gilbert et al., 2019; Machado & Cerca, 2015; Muzny et al., 2019, 2020;
Randis & Ratner, 2019). Just as in the gut and respiratory tract, Prevotella in the vaginal
microbiome contributes to the pathogenesis in a polymicrobial context via metabolic modulation
of the vaginal microenvironment.
1.2 Genomic diversity within the genus Prevotella
Before sequencing based techniques, diversity within the genus Prevotella was typically
thought of in the context of its phenotypic and metabolic diversity, leading to frequent
reclassification or definition of new species within groups of Prevotella isolates (Avguštin et al.,
1997; Kononen et al., 1998; Könönen et al., 1998). This diversity was confirmed with
sequencing-based techniques that helped study Prevotella at the genomic level. Prevotella
shows great diversity in the anatomic site and the host and environment it can be found in.
Whole genomes of Prevotella can vary greatly in length (~2 – 4Mb), number of coding sequences
(2000 – 3300), number of genes (2,600 – 10,400) and GC content (36.4 – 56.1%) (Tett et al.,
2021). Furthermore, comparative analysis of representative Prevotella whole genomes from
across the genus shows an anatomic site specific gene repertoire where the distribution of the
functions of orthologous clusters were also highly anatomic site specific (Gupta et al., 2015).
The literature on the comparative genomics of Prevotella at the whole genome level is
relatively sparse and when available has been done using only a few representative genomes.
One of the largest comparative genome analyses done in Prevotella is in P. copri using whole
genomes reconstructed from metagenomic samples. This work shows that P. copri is a complex
comprising of four distinct clades that can be classified as four different species based on their
average nucleotide identity (ANI) scores. P. copri strains also have distinct polysaccharide
utilization profiles where the loci were varied in the carbohydrate catabolic enzymes they
contained (Fehlner-Peach et al., 2019b; Tett et al., 2019). This suggests that the influence of P.
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copri on disease could be better understood by studying the metabolic changes it enacts onto the
microenvironment of the gut.
P. copri is not the only gut bacteria able to breakdown complex sugars. Functional
analysis of representative whole genomes of P. bryantii and P. ruminicola shows that between
the two genomes over 100 carbohydrate active enzymes are encoded, with both having their own
unique subset of enzymatic genes. P. ruminicola has ORFs not found in P. bryantii that are
predicted to be glycan-degrading enzymes whereas P. bryantii has a more extensive repertoire of
pectin-cleaving enzymes than P. ruminicola. This study also identifies CRISPR spacer regions
and ORFs annotated as part of the conjugative protein family of tra genes, indicating the
presence of multiple mechanisms of horizontal gene transfer (HGT) that could contribute to the
diversity in the genomes (Nathani et al., 2015; Purushe et al., 2010). Similar comparisons of
representative genomes of oral Prevotella species shows a variation in their polysaccharide
utilization gene repertoire. Oral Prevotella also encode ORFs that correspond to multiple
mechanisms of HGT like CRISPR-Cas9 systems and competence proteins (Ibrahim et al., 2017).
Population-genomic comparisons of P. intermedia and P. nigrescens from the oral cavity of
healthy individuals and periodontitis clinical isolates not only predict multiple mobile genetic
elements that can contribute to HGT but appear more frequent in healthy individuals. P. copri, P.
nigrescens and P. intermedia also show distinct metabolic activities between clinical isolates and
healthy controls (Olsen et al., 2017). Overall, the comparative genomics analysis of Prevotella
genomes agree on its genomic plasticity, indicating that Prevotella has the ability to mutate or
exchange genomic DNA to either change and/or adapt to the microenvironment it resides in.
1.3 Prevotella during infection and inflammation
Many of the in vitro and in vivo studies on Prevotella infection are focused on only a few
species of interest like P. nigrescens, P. intermedia and P. copri. This focus is likely because
only a few species are canonically recognized as having a pathogenic role in disease.
Furthermore, there are conflicting reports whether infection with Prevotella can promote or
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dampen inflammatory responses. Various Prevotella species can promote inflammation via the
Th-17 response pathway (Larsen, 2017). Infection of a RA mouse model with P. copri rapidly
induced arthritis in mice via IL-17 production from dendritic cells (Maeda et al., 2016). The
periodontitis associated P. nigrescens similarly aggravated the severity of RA via a Th-17
phenotype driven by TLR2 and IL-1 activation (de Aquino et al., 2014). TLR2 signaling by the
activation of the canonical NF-κB pathway, mediated by the nuclear p65 DNA binding protein,
was how P. nigrescens promoted inflammation in a CF bronchial epithelial cell line (A. Bertelsen
et al., 2020). In murine bone marrow-derived dendritic cells, P. nigrescens can promote
inflammation via TLR2 signaling and NLRP3 inflammasome activation (Jang et al., 2021).
However, it has been reported that species like P. histicola and P. nigrescens can also mute the
inflammatory responses in CF bronchial epithelial cells via the alternative NF-κB signaling
pathway, which might be suppressing the canonical NF-κB pathway. This in turn can reduce P.
aeruginosa growth, and P. aeruginosa mediated inflammatory responses like TLR4 expression
and release of IL-6 and IL-8 cytokines in a CF bronchial epithelial cell line (Anne Bertelsen et al.,
2020, 2021).
In a study of the gut microbiome of commercially raised pigs fed on a formula of a high
carbohydrate and high protein diet, a high abundance of P. copri was positively correlated with
the levels of serum metabolites associated with obesity like branched chain amino acids, just like
in humans, and increased intestinal barrier permeability and chronic inflammation. Germ-free
mice gavaged with the intestinal P. copri of pigs showed activation of the TLR4 and mTOR
signaling pathways (C. Chen et al., 2021). Intestinal colonization of C57BL/6 mice with of P. copri
makes them more susceptible to chemically induced colitis (Scher et al., 2013). Similarly, in a
carboplatin induced mucositis mouse model, higher levels of P. copri resulted in more severe
intestinal tissue damage, higher levels of cytokine production and lower tight junction protein
expression (Yu et al., 2019). Other gut associated Prevotella like P. intestinalis can also
exacerbate intestinal mucosal inflammation via the production of short-chain fatty acids that has
an immunomodulatory effect in the gut microenvironment by decreasing levels of IL-18 (Iljazovic
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et al., 2021). These studies reveal a few mechanisms with which Prevotella might be causing
cytotoxicity and inflammation in the microbiome of chronic inflammatory diseases and show its
varied immunomodulatory potential.
1.4 Dissertation Aims
Prevotella is a genus of anaerobic bacteria that is enriched in the microbiomes of many
chronic inflammatory diseases. In the context of CF especially, its role in disease is unclear due
to its association with both diverse microbiomes characteristic of mild disease and the less
diverse microbiome of later stage disease. It has been shown that Prevotella can have high
genomic heterogeneity not just at the genus level but, as demonstrated in the gut associated P.
copri, at the species level as well. Additionally, this heterogeneity extends to the phenotypic level
where Prevotella species can greatly influence the metabolic environment of microbiomes due to
their ability to process complex carbohydrates and dietary fiber. Despite the evidence that
different Prevotella species can have differential functional effects on the microbiome in the oral
cavity, gut and vagina, effects of Prevotella on the lower respiratory tract, especially at the
species level, is greatly understudied. My thesis demonstrates the need to study Prevotella at the
species level in the context of CF by demonstrating the genomic diversity within P.
melaninogenica and its closely related species.
1.4.1 Aim 1: Ecological characterization of the longitudinal pediatric cohort EcoCF
In chapter 2 we sought to characterize the ecology of our longitudinal prospective
pediatric cohort called EcoCF. We aimed to define some common metrics like lung function, age
and clinical status with the microbial ecology of the microbiome samples. We found that lung
function was positively correlated with alpha diversity and negatively correlated with age in the
baseline and exacerbation clinical states. Alpha diversity was also higher in baseline samples in
comparison to samples from patients undergoing pulmonary exacerbation. We also found that
the genus Prevotella along with genera that contain canonical CF pathogens like
Stenotrophomonas, Staphylococcus and Pseudomonas is differentially abundant in samples
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corresponding to lower lung function measured by FEV1% potential. Treatment with antibiotics,
both prescribed for acute treatment of pulmonary exacerbations and for long-term maintenance,
lowered the alpha diversity of samples. However, long term maintenance antibiotics like
azithromycin and tobramycin lowered alpha diversity of samples only up to a threshold FEV1%
predicted, below which the mean alpha diversity remained similar regardless of antibiotic use.
We also defined our CF samples in terms of their dominant taxon and looked at the
microbial composition and dominant taxon transition dynamics longitudinally. We found that
Streptococcus and Prevotella were the most dominant taxa in samples with high alpha diversity.
Whereas Streptococcus dominant samples were relatively stable in the next timepoint i.e. 60% of
Streptococcus dominant samples stayed Streptococcus, Prevotella dominant samples were more
likely to switch their dominant taxon in the next timepoint. This suggests that Prevotella
dominance is possibly indicative of a microenvironment favorable for colonization by other taxa.
1.4.2 Aim 2: Genomic diversity and mechanisms of HGT in P. melaninogenica
The aim of chapter 3 was to show the genomic heterogeneity of P. melaninogenica to
understand why Prevotella can be associated with both mild and severe lung disease in CF. P.
melaninogenica is a species commonly found and isolated from the CF lung. P. melaninogenica
groups together with other oral commensals that are also often found in the CF lung like P.
denticola and P. histicola. We show that P. melaninogenica is a species complex comprising of
at least four different species. We also show that species resolution by 16S variable regions are
limited and therefore not appropriate to study Prevotella associations with the microbiome at the
strain-level. We defined four species within the currently defined P. melaninogenica: P.
melaninogenica sensu stricto, P. scopos, P. allisoniae and Prevotella spp. GAI07411, which is a
single taxon that forms a clade on its own and doesn’t share a high ANI score with any other taxa
in our analysis.
To understand how Prevotella maintains such genomic diversity we further investigated
various mechanisms of HGT in P. melaninogenica. We find that P. melaninogenica and its
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closely related species have high recombination rates and that the minor chromosome,
chromosome II, of Prevotella genomes tends to be more diverse than chromosome I. However,
when characterizing the R-M systems in the P. allisoniae 361B strain using its genome
methylation signatures, we find four different R-M systems that never overlap entirely with any
other genome in our analysis. This indicates that despite the genomic diversity there is also
significant barriers to HGT within the genus Prevotella. Taken together, the interplay of different
mechanisms of horizontal gene transfer (HGT) in Prevotella likely contribute to the overall
maintenance of this diverse genus and possibly aids its ability to thrive in microenvironments of
both health and disease associated microbiomes.
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2

CHAPTER 2: LONGITUDINAL MICROBIAL ECOLOGY IN PEDIATRIC
PATIENTS WITH CYSTIC FIBROSIS

This chapter contains unpublished data from a manuscript in prep by Prioty F. Sarwar*, Gina T.
Coscia,* Ceylan Tanes*, Jonathan Leff, Tobin Hammer, Rose Carlson, Melanie Harasym,
Hannah Smith,Chanelle Ryan, Samuel LaRussa, Evan Cantor, Tamar Yamany, Lynne Quittell,
Lisa Saiman, Alice Prince, Kyle Bittinger, Noah Fierer, Paul J. Planet *indicates co-first authorship

2.1 Abstract
Despite significant advances in our understanding to of the cystic fibrosis (CF)
microbiome, it is unclear if changes in the respiratory microbiome correspond to changes in
clinical status. In this chapter, we attempted to characterize the ecology of our longitudinal
pediatric CF cohort. To this end, we discuss the relationship between changes in the respiratory
microbiome with clinical status or antibiotic use. We also show the dynamics of the most
dominant taxon in our samples longitudinally as CF samples are often defined by one very
dominant taxon, especially during later stage disease. We analyzed 844 samples from 169
patients over 4 years. Bacterial community diversity remained stable between baseline and
exacerbation states but changed markedly and decreased during treatment with antibiotics for
pulmonary exacerbations. Maintenance antibiotics also lowered the alpha diversity of samples
but below a certain threshold FEV1% it did not change alpha diversity. Lower lung function
correlated with decreased bacterial diversity and even though diversity is thought to decrease
with age, in our cohort, we did not identify this correlation. There is general stability in the
microbiome between baseline and exacerbation states suggesting that large-scale changes in
diversity are probably not responsible for exacerbation. It is unclear whether the changes in
diversity during treatment are therapeutic or a byproduct of antibiotic therapy. Higher lung
function is associated with higher microbial diversity, signaling a possible role for the microbiome
in chronic disease progression.
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2.2 Introduction
The impact of the airway microbiome on cystic fibrosis (CF) patients is the subject of
immense interest, driven by the increasing availability of an array of culture-independent
techniques such as: genetic fingerprinting by T-RFLP (Daniels et al., 2013; Harris et al., 2007;
Geraint B. Rogers et al., 2010; C D Sibley et al., 2011; Christopher D Sibley et al., 2008;
Franziska A. Stressmann et al., 2011; Franziska Anne Stressmann et al., 2012; M M Tunney et
al., 2011), qPCR (Carmody et al., 2013; Cox et al., 2010; M M Tunney et al., 2011; E T Zemanick
et al., 2010; Zhao et al., 2012), “phylochip” microarray hybridization (Cox et al., 2010), 16S-based
Sanger and next-generation sequencing (Carmody et al., 2013, 2018; Cuthbertson et al., 2020;
Fodor et al., 2012b; Laguna et al., 2016; Layeghifard et al., 2019; Van Der Gast et al., 2014; Zhao
et al., 2012), and whole-genome sequencing (Hauser et al., 2014a). Culture-independent
technology has allowed us to appreciate the sheer diversity of microorganisms that make up the
CF respiratory microbiomes. It has also expanded our focus beyond just the ‘typical CF
pathogens’ like Pseudomonas aeruginosa, Staphylococcus aureus, Haemophilus influenzae etc.
to bacteria with an underappreciated clinical significance like anaerobes (Carmody et al., 2018;
Coburn et al., 2015; Layeghifard et al., 2019; Mahboubi et al., 2016; Sherrard, Bell, et al., 2016).
The ultimate goal of CF microbiome research has been to define the role that the
microbiota plays in disease, with ongoing efforts to understand the relationship between
polymicrobial respiratory communities with acute clinical decompensations like pulmonary
exacerbations during CF, and later stage disease. Cross-sectional studies initially suggested that
bacterial community diversity correlates inversely with age (Cox et al., 2010; Klepac-Ceraj et al.,
2010) and by extension, that diversity correlates positively with lung function. Longitudinal
studies (Fodor et al., 2012a; Franziska Anne Stressmann et al., 2012; Zhao et al., 2012) have
demonstrated overall resilience and stability in the CF airway microbiota, despite intermittent
perturbations. However, studies have been limited in their ability to show significant changes in
community diversity between samples obtained from baseline and exacerbation states (Carmody
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et al., 2013; Fodor et al., 2012a; Zhao et al., 2012), although some have shown an increase in the
relative abundance of anaerobic bacteria during pulmonary exacerbations in early stage disease
(Carmody et al., 2013, 2018). Recent efforts have been made to understand the CF microbiome
from the perspective of ecological networks. Network analysis has allowed researchers to
identify two major functional communities in a climax-attack model (CAM) where the ‘attack’
community consists of more transient taxa that induce strong innate immune responses and the
‘climax’ which consists of more stable taxa, resistant to antibiotic therapy (Conrad et al., 2013;
Khanolkar et al., 2020; Quinn et al., 2016). Layeghifard et al (2019) used network analysis to
show a shift in community structure during pulmonary exacerbations which is associated with an
increase in anaerobic and facultatively anaerobic bacteria (Layeghifard et al., 2019).
Microbiome studies have also shown that antibiotic use, both long-term maintenance and
acute therapy for exacerbations can have a robust impact on the CF respiratory microbiome but
the overall impact on community richness or phylogenetic diversity remain unclear (Daniels et al.,
2013; Fodor et al., 2012a; Klepac-Ceraj et al., 2010; M M Tunney et al., 2011; Zhao et al., 2012).
For instance, it is not clear if antibiotics are strongly predictive of changes in diversity (Zhao et al.,
2012, 2014) or have little to no effect on community structure (Fodor et al., 2012a). Furthermore,
it has been shown that maintenance antibiotics affect the relative abundance of ‘off-target’ taxa
more than they do pathogens like Pseudomonas aeruginosa or Staphylococcus aureus (Heirali et
al., 2019; Nelson et al., 2020).
Despite significant progress in the field, microbiome analysis is often limited by the lack of
longitudinal data or small sample size. Pediatric studies are limited in their ability to investigate
lower respiratory tract microbiomes due to the patients’ inability to expectorate sputum. Here we
present the largest prospective longitudinal cohort of pediatric patients to date with 169
participants and 844 samples of oral swabs, sputum and bronchioalveolar lavage (BAL) fluid
collected at times of routine clinical care. We show that in our cohort clinical changes only
minimally contribute to overall change in alpha diversity of the microbial community, and that
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acute antibiotics during treatment of pulmonary exacerbation are strongly linked to community
change. Even though maintenance antibiotics are associated with lower community richness, the
community appears resistant to change at lower lung function. Additionally, we analyze the
impact of dominant taxa on the lung function and alpha diversity, and model the transition
dynamics of samples based on its dominant taxon and clinical status.

2.3 Methods
2.3.1 Subjects and sampling
Approval for the study was obtained from the Columbia University Medical Center
Institutional Review Board and informed consent or assent was obtained from all subjects or their
guardians. Samples collected from 169 pediatric patients with cystic fibrosis over the course of
four years from 20-23-2010 to 06-05-2014 were included in this study. Our inclusion criteria
were: 1) diagnosis of CF based on positive sweat chloride test (>60) and/or presence of CF
disease-causing mutations, and 2) receipt of medical care at our CF center. Oropharyngeal (OP)
swabs, sputum, and BAL samples were obtained in CF patients in the inpatient and outpatient
settings. Samples were archived on the day of collection at –80°C in three forms: 1) raw (swabs
were swirled in 1mL of DPBS; sputum and BAL fluid were saved in original form) 2) in a final 25%
glycerol suspension and 3) in 10% Dimethyl sulfoxide (DMSO). Spirometry was recorded for
each patient according the American Thoracic Society Guidelines (“Standardization of
Spirometry, 1994 Update,” 1995) during each visit, prior to sample retrieval and clinical
classification of the patient at each visit was assigned to one of four clinical states: baseline,
exacerbation, treatment and recovery (BETR; Table 2) (Treggiari et al., 2009; Zhao et al., 2012)
based on medical record review.
2.3.2 Sample processing and library preparation
Genomic DNA was extracted from samples using the PowerSoil® DNA Isolation Kit, Mo
Bio Laboratories. For OP swabs and BAL, 300µL aliquot of raw sample and 300g of sputum was
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used for DNA extraction. The V4 region of the 16S rRNA gene was amplified with the forward
primer 515F (5’-3’: GTGCCAGCMGCCGCGGTAA) and the reverse primer 806R (5’-3’:
GGACTACVSGGGTATCTAAT) and sequenced using Illumina MiSeq platform.
2.3.3 Bioinformatics analysis
Sequence reads were processed using QIIME version 1.9 (Gregory Caporaso et al.,
2010). Read pairs were joined to form a complete amplicon sequence for the V4 region of the
16S rRNA marker gene, with a minimum overlap of 35 base pairs and a maximum sequence
dissimilarity of 15% within the overlapping region. After joining, sequences were filtered to
remove low quality reads, with a minimum quality threshold of Q20. Operational Taxonomic Units
(OTUs) were generated at 97% sequence similarity using UCLUST version 1.2.22 (Edgar &
Bateman, 2010). Taxonomic assignments were generated using the consensus method in
QIIME, with a similarity threshold of 90% to sequences in the Greengenes reference database
version 13_8 (Mcdonald et al., 2012). A phylogenetic tree was inferred from the OTU
representative sequences using FastTree2 (Price et al., 2010). Similarity between samples was
assessed by weighted and unweighted UniFrac distance (Lozupone & Knight, 2005).
Additionally, sequence reads were analyzed using the web-based data mining platform
MicrobiomeDB (Oliveira et al., 2018) for a subset of the analysis which uses a DADA2 pipeline to
analyze 16S sequences and DESeq2 pipeline to make differential abundance analysis.
2.3.4 Statistical analysis
Data files from QIIME and MicrobiomeDB were analyzed and visualized in the R
environment. Unweighted and weighted UniFrac distances between samples were visualized
using Principal Coordinate Analysis (PCoA). Simpson diversity was defined as

where

is the relative abundance of the taxa and calculated using the vegan package in R (Jari Oksanen,
F. Guillaume Blanchet, Michael Friendly, Roeland Kindt, Pierre Legendre, Dan McGlinn, Peter R.
Minchin, R. B. O’Hara, Gavin L. Simpson, Peter Solymos, M. Henry H. Stevens, Eduard Szoecs,
2020). Simpson diversity and bacterial taxon abundance were assessed using generalized linear
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mixed effects models. Comparison of the relative abundances of different taxa was assessed
using linear regressing models. Multiple tests were corrected to control for the false discovery
rate, using the method of Benjamini and Hochburg (Yoav Benjamini, 1995) and Tukey’s HSD
(Haynes, 2013). The taxon with the highest relative abundance in a sample was defined as the
dominant taxon. Swab samples were clustered with partitioning around medioids (PAM) using the
number of clusters that would result in the highest silhouette score. Markov chain transition
probabilities for consecutive swab samples were calculated with either BETR annotations or the
dominant taxa as the transition states.

2.4 Results
2.4.1 Patient characteristics
Over the course of 4 years, 686 OP swab, 122 sputum and 28 BAL samples were
collected from 169 patients. Subjects ranged in age from 18 days to 21 years. The predominant
CFTR genotype was homozygous for ΔF508 the CFTR allele (40%) and evenly split between
male and female. The FEV1% predicted ranged from 21% to 144%, the overall median of
FEV1% predicted was 80%. Younger patients had a higher median of FEV1% predicted than
those in later age groups (Table 1). We used clinical categories adapted from prior work by Zhao
et.al(Zhao et al., 2012) to categorize patients into one of four clinical statuses defined by the
EPIC observational study (Treggiari et al., 2009): baseline (B), exacerbation (E), treatment (T),
and recovery (R) at the time of sample collection (Table 2). The most significant number of
samples fell into either the baseline ‘B’ (56%) or exacerbation ‘E’ (22%) group.
2.4.2 Sequencing results
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The samples were sequenced in two batches on Illumina MiSeq machine resulting in 40
million read pairs. The mean read count per sample was 16,562. UCLUST(Edgar & Bateman,
2010) yielded 183,629 distinct OTUs at 97% sequence similarity.

Table 2.1. Patient and sample characteristics of the longitudinal pediatric EcoCF cohort.
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Table 2.2. Definition of the BETR clinical categories.
Adapted from Treggiari et al. (2009)(Treggiari et al., 2009) and Zhao et al. (2010)(Zhao et al.,
2012)

2.4.3 Community diversity relative to clinical state and lung function
To assess the association between lung function and microbial diversity in samples, we
compared the FEV1% predicted values that were recorded on the same day as sample collection
to its Simpson diversity index. Concordant with previous observations (Coburn et al., 2015), we
observed a positive correlation between lung function and Simpson diversity (p<0.001; Fig 2.1A)
and a negative correlation between lung function and age (p<0.001; Fig 2.1C). However, there
was no significant association between age and Simpson diversity (p=0.3). Six taxa were found
to be differentially abundant between high (80<FEV1%<=144) and low (21<FEV1%<=80) lung
function categories. Prevotella (p<0.01), Staphylococcus (p<0.0001), Stenotrophomonas
(p<0.0001) and Pseudomonas (p<0.0001) were enriched in the low lung function group with
Pseudomonas demonstrating the largest and Prevotella demonstrating a relatively modest fold
change. On the other hand, Neisseria and Leptotrichia were modestly enriched (p<0.01) in the
high lung function category (Fig 2.1F).
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We categorized patients into one of four clinical statuses, namely, baseline (B),
exacerbation (E), treatment (T), and recovery (R) at the time of sample collection. To
characterize the microbiome communities across these different clinical states we compared the
alpha diversity assessed by the Simpson diversity index. The average Simpson diversity of the
OP samples was lower for all exacerbation (p=0.03), treatment (p<0.001) and recovery stages
(p=0.002) compared to baseline (Fig 2.1B). There was no significant difference of Simpson
diversity between disease stages for sputum or BAL samples.

Fig 2.1. Patient characteristics and bacterial community overview.
(A) Simpson diversity of samples over the lung function of the subjects colored by the age of the
subject at collection. (B) Simpson diversity of the samples with respect to their BETR status of the
patients and the sample type. (C) Age of the subjects in years over their lung function (FEV1%)
stratified by their BETR status. (D) Principle coordinate plot of the weighted UniFrac distances
faceted by the sample type and colored by the patient’s BETR status. Axes are labeled with the
variance explained by the corresponding axis. (E) Comparison of the Pairwise unweighted
UniFrac distances of swab and sputum samples. (F) Differential abundance of taxa in patients
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with high lung function (80 < FEV1% <= 144) and low lung function (21 < FEV1% <= 80). Panel F
was generated using MicrobiomeDB.

2.4.4 Correlation between the sputum and oropharyngeal microbiota
Many of our samples are OP swabs because many pediatric patients cannot reliably
produce sputum. We wanted to address the difference between OP swabs and expectorated
sputum samples in our cohort to partially address controversy about the differences in the
microbiota from different anatomical sites and sample types. To test if the OP swab samples
reflected the sputum bacterial community, we compared the within and between unweighted
UniFrac distances of 13 swab and sputum sample pairs collected on the same day from the same
patient. The distances within swab samples from the same patient collected at different time
points were greater than the distances between the 13 swab-sputum pairs (p=0.004; Fig 2.1E),
providing evidence of correlation between the oropharyngeal and sputum microbiota in CF
subjects.
2.4.5 Chronic Antibiotic Use and Sample Diversity
Given that the treatment groups displayed the greatest differences in diversity, it is likely
that episodic use of antibiotics is a potent force affecting the microbiome. However, since many
CF patients also use chronic antibiotics such as inhaled tobramycin or oral azithromycin, we
sought to determine any effects these medications might have. Participants in our study were
prescribed four distinct maintenance antibiotics either on their own or in combination:
azithromycin, tobramycin, colistin and aztreonam. Most patients (n=22) were combination users
of azithromycin and tobramycin. Only 6 and 8 patients respectively were solely using
maintenance azithromycin or tobramycin.
To see the effect of maintenance antibiotic use on Simpson diversity, we constructed a
smooth curve fit to patients who use tobramycin and/or azithromycin and to patients who do not.
As expected, samples from tobramycin or azithromycin users have lower Simpson diversity than
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those who do not. However, plotted over FEV1%, we can see that the potential effect of
maintenance antibiotic use on Simpson diversity is impactful only up to a certain FEV1%
threshold. Inhaled tobramycin is associated with lower Simpson diversity only in patients with
FEV1% predicted above 84%. Similarly, the association of oral azithromycin with lower Simpson
diversity also disappears when FEV1% predicted is below 65% (Fig 2.2B).

Fig 2.2. Maintenance antibiotic use compared to the Simpson diversity of samples and
differential abundance of taxa.
(A) The number of patients on the four maintenance antibiotics used in the EcoCF cohort. (B)
Simpson diversity of samples over the lung function (FEV1%) of the subjects colored by
maintenance azithromycin or tobramycin use. (C) Differential abundance of taxa in samples
depending on azithromycin, tobramycin use and tobramycin use in samples that don’t have
Pseudomonas. Panels B-C was generated using MicrobiomeDB.

To show whether this effect is replicated when the confounding effect of patients on
multiple maintenance antibiotics is removed, we repeated this analysis to compare only
tobramycin or only azithromycin users versus patients not on any maintenance antibiotics. For
inhaled tobramycin, the pattern is repeated where the reduction in Simpson diversity is most
noticeable above 84% FEV1% predicted, even though the pattern does not hold for azithromycin
(Fig 2.3A-B). Due to the low number of samples affecting the local regression and the
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‘smoothing’ of the curve especially at low lung function, it is not possible to conclude whether the
pattern seen using all samples versus only the subset of one antibiotic user is meaningfully
different.
Inhaled tobramycin is often prescribed as a treatment for Pseudomonas infection in CF
patients, and it has been shown previously that tobramycin use has mostly off-target effects on
the taxonomic composition of samples (Nelson et al., 2020). We looked at the differential
abundance in samples from patients who were only tobramycin users versus those who were not
on antibiotics. We found that when tobramycin was used, Granulicatella and Actinomyces
relative abundance was reduced while Staphylococcus was increased (p<0.01; Fig 2.3D). The
increase in Staphylococcus can also be seen when we look at the differential abundance caused
by tobramycin use in all samples and in samples that do not have Pseudomonas (Fig 2.2). When
only samples that contained Pseudomonas were considered, tobramycin use did not have any
differentially abundant OTUs.
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Fig 2.3. Simpson diversity and differential abundance of taxa in samples from either only
maintenance tobramycin or only maintenance azithromycin users.
Simpson alpha diversity over lung function of subjects who were only on maintenance (A)
azithromycin or (B) tobramycin. Differential abundance of taxa in subjects who were only on
maintenance (C) azithromycin or (D) tobramycin. Figure was generated using MicrobiomeDB.

2.4.6 The CF oropharyngeal microbiota is characterized by extremely dominant taxa
We observed that in many of our samples a single taxon would have a high relative
abundance (>0.25) (Fig 2.4C) leading to an overall lower Simpson diversity. Therefore, we
wanted to characterize our dataset according to the most dominant taxon. We annotated each
sample with its highest abundant taxon as the dominant taxon. Out of 683 swab samples,
Streptococcus was the most common dominant taxon with 341 samples, followed by Prevotella
(98 samples), Neisseria (44 samples), Staphylococcus (37 samples) and Pseudomonas (32
samples). The relative abundance distribution of the eight most frequently dominant taxa shows
that Streptococcus, Prevotella and Neisseria can often take up a quarter of the total abundance in
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a sample. Fig 2.4A shows the Simpson diversity of the samples with respect to their dominant
taxon. Samples dominated with Xanthomonadaceae (P<0.001), Pseudomonas (P<0.001) and
Enterobacteriaceae (P<0.001) had lower diversity compared to samples dominated with
Streptococcus or Prevotella. Pseudomonas and Enterobacteriaceae dominant samples follow a
trend of having lower FEV1% predicted but the results were not statistically significant.
2.4.7 Culture does not reflect the dominant taxa in samples
Culture results from the clinical microbiology lab were obtained for 315 samples in the
dataset. We compared the culture results to their corresponding relative abundance from 16S
rRNA marker gene sequencing. Figure 2.5A shows that Pseudomonas, Staphylococcus,
Burkholderia and Achromobacter had higher mean abundances for the samples that tested
positive than for those bacteria than culture negative samples. However, most of the taxa that
tested positive had low relative abundances in the 16S rRNA gene data results, suggesting
cultured bacteria may constitute a small fraction of total bacterial cells in the community,
consistent with previous findings in the BAL fluid (Zachariah et al., 2018). Furthermore, we
looked at the culture positivity rate for the dominant taxon of the cultured samples. Aside from
Pseudomonas and Staphylococcus, the most dominant taxa in the community were not reliably
detected in the culture results (Fig 2.5B). For some of the taxa this is likely because clinical
microbiology does not perform the culture conditions required (Prevotella, Haemophilus) or they
are disregarded as common respiratory flora (Streptococcus). But Xanthomonadaceae and
Enterobacteriaceae, which could represent the genera Stenotrophomonas and Escherichia or
Klebsiella among others, would usually be cultured and identified. This suggests that the
predominant organism, even if it would often be recognized if cultured, are often negative by
culture.
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Fig 2.4. Alpha diversity and lung function of samples based on the dominant taxon.
(A) Simpson diversity and (B) FEV1% of samples based on the sample’s dominant taxon. (C)
Distribution of the relative abundances of the 9 dominant taxon categories. Each swab sample
has been annotated with the most abundant taxon present. The taxa that are dominant in less
than 20 swab samples have been categorized as “other”. Enterobacteriaceae and
Xanthomonadaceae could not be resolved beyond the family level by 16S sequencing. Both (A)
and (B) has been sorted with decreasing median Simpson diversity. The colors represent the
sample types.
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Fig 2.5. Culture results and relative abundance of the 8 most dominant taxon.
(A) Relative abundance of commonly lab cultured taxa in samples grouped by whether the
sample was culture positive or negative for that taxon. Enterobacteriaceae and
Xanthomonadaceae could not be resolved beyond the family level by 16S sequencing. (B) The
percentage of samples that are culture positive for the most dominant organism in that sample.

2.4.8 Continuum of Streptococcus and Prevotella dominated communities
Streptococcus and Prevotella were the two most common taxa that dominated the swab
samples associated with high Simpson diversity in our cohort. The PCoA plot in Fig 2.6A shows
that Streptococcus and Prevotella have the biggest impact on the variation between our samples.
To investigate relative abundance patterns between Streptococcus and Prevetolla, and other less
abundant genera, we computed the correlation between genus abundance and each axis of the
PCoA plot. The first axis is highly correlated with Streptococcus and Prevotella abundance
(p<0.001) and is not correlated with either age or the lung function of the patients. In fact, the
ratio of Prevotella to Streptococcus abundance barely changed with increasing age (Fig 2.6B).
The second PCoA axis is correlated with the relative abundance of Rothia, Haemophilus, and
Neisseria (P<0.001). The relative abundance of Haemophilus and Neisseria was positively
associated with higher lung function and younger subjects (P<0.001).
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Fig 2.6. Analysis with Streptococcus and Prevotella dominant swab samples.
(A) Principle coordinate plot of the weighted UniFrac distances of the swab samples that have
either Streptococcus, Prevotella or Neisseria as the dominant taxon. Axes are labeled with the
variance they explain in the data. The subplots represent the moving average relative abundance
of a taxon that is correlated with the axis. (B) Prevotella / Streptococcus ratio and correlation with
age.

2.4.9 Clusters of Pseudomonas dominated communities
Pseudomonas infections are common in patients with CF. Samples containing
Pseudomonas were resistant to change by inhaled tobramycin use and commonly dominated the
low Simpson diversity swab samples in our cohort. Therefore, we characterized the
Pseudomonas dominant samples separately. We clustered the samples with PAM into three
groups with an average silhouette score 0.41 indicating moderately strong evidence of clusters
(Fig 2.7B). Clusters 2 (green) and 3 (yellow) are distinctly Pseudomonas dominated while cluster
1 (pink) has high relative abundance of Staphylococcus and anaerobes (Fig 2.7C) in addition to
Pseudomonas. The clusters were not associated with a significant difference in the levels of
Pseudomonas, lung function, or age.
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Fig 2.7. Analysis of Pseudomonas dominated samples of all sample types.
(A) Sample and patient characteristics and relative abundance of other OTUs. (B) Principal
component plot of Pseudomonas dominant samples using normalized weighted UniFrac
distances colored by PAM clusters of the Pseudomonas dominated samples. (C) Relative
abundance of the 9 taxa with the highest mean relative abundance stratified by the 3 PAM
clusters

We further investigated the relationship between Pseudomonas and Staphylococcus with
some of the anaerobes from cluster 1: Haemophilus, Rothia, Prevotella and Streptococcus.
Additionally, we also included Neisseria in this analysis since, like the rest, it is associated with a
PCoA axis of high diversity samples from Fig 2.6A. Anaerobic taxa are often correlated with high
diversity and high lung function (Coburn et al., 2015; Cuthbertson et al., 2020) leading us to
hypothesize a general negative correlation with Staphylococcus and Pseudomonas. In samples
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where they co-occur, Pseudomonas was only significantly negatively correlated with
Haemophilus (p<0.05; Fig 2.8A) while Staphylococcus showed no association with any of our
taxa of interest (Fig 2.8C). When stratified for the presence and absence of our taxa of interest
we found that Pseudomonas had lower relative abundance in samples that are positive for
Haemophilus (p<0.001), Prevotella (p<0.0001) and Streptococcus (p<0.05; Fig 2.8B) and
Staphylococcus had lower relative abundance in samples that are positive for Neisseria
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(p<0.001), Prevotella (p<0.01) and Rothia (p<0.05; Fig 2.8D).
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Fig 2.8. Correlation of the relative abundances of Pseudomonas and Staphylococcus with
taxa associated with high Simpson diversity.
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(A) The relative abundance of Pseudomonas over the relative abundance of other taxa in
samples where they co-occur. (B) The relative abundance of Pseudomonas in samples stratified
for the presence and absence of our taxa of interest. (C) The relative abundance of
Staphylococcus over the relative abundance of other taxa in samples where they co-occur. (D)
The relative abundance of Staphylococcus in samples stratified for the presence and absence of
our taxa of interest. Multiple linear regression analysis was run for (A) and (C) and Two-way
ANOVA with Tukey’s multiple correction was run on the untransformed data in (B) and (D)*
p<0.05 ** p < 0.01 *** p<0.001 **** p<0.0001. Figure was generated in R using MicrobiomeDB
data outputs.

2.4.10 Longitudinal community dynamics
Multiple swab samples were collected from 169 patients at different disease stages,
allowing us to investigate the longitudinal dynamics of bacterial communities in the oropharyngeal
swab samples. To characterize the changes between time points, we calculated transition
probabilities of a Markov chain with either the BETR annotations or the dominant taxa as the
transition states. Fig 2.9A illustrates the transitions between the dominant taxa for consecutive
swab samples.
Streptococcus dominant was the most stable state. Streptococcus dominated swab
samples made up 50% of the cohort, and within those samples, 60% stayed in that dominant
state at the next sample collection, whereas among the samples that are dominated with
Prevotella only 30% stayed in the same state (Fig 2.9B). The proportion of samples that stayed
in the Streptococcus dominant state was higher than other states (p<0.001, Chi-squared test). If
Pseudomonas was dominant in a swab sample, 17% of those samples switched to an
exacerbation from baseline state at the next sample collection. This is the highest percentage of
baseline to exacerbation transition compared to other dominant taxa.
The abundance of the most dominant taxon was not predictive for a transition to another
dominant state (Fig 2.9D). Furthermore, we found that the BETR scores were not associated
with the dominance of a specific taxon. However, it was more likely that the dominant taxon
would change if the BETR status of the patient had changed (p=0.02, Chi-squared test). For
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subjects classified in a baseline state, we found that the bacterial community was generally stable
but not predictive of a change in BETR status. The distance between pairwise non-consecutive
baseline samples had higher unweighted UniFrac distance than consecutive baseline sample
distances (p<0.001). Consecutive baseline-exacerbation samples do not significantly alter the
community than consecutive baseline samples.

Fig 2.9. Transition dynamics of samples based on its dominant taxon or BETR clinical
state

37

(A) Alluvial diagram of dominant taxa transitions between consecutive swab samples from the
same patient. The width of the ribbons represent the percentage of swab samples that switch
between the taxa noted on the “from” and “to” columns. (B) The number of swab samples that
have the same dominant taxon in the next time point. Total represents the number of samples
with the corresponding dominant taxon. Expected represents the number of samples expected to
have the same dominant taxon in the next time step assuming equal probability. Expected
represents the actual number of samples with the same dominant taxon. (C) The number of swab
samples that stay or switch between the BETR states and the dominant taxon. (D) The relative
abundance of dominant taxon stratified by whether the next collected sample had switched the
dominant taxon.

2.5 Discussion
This is the largest longitudinal study of pediatric patients with CF to characterize the
respiratory microbiome. We observed a decline in the alpha diversity of samples with decreasing
lung function, in older patients and patients in the treatment (T) group undergoing acute antibiotic
therapy due to an exacerbation (Fig 2.1A-C). Our results corroborate those from prior
longitudinal studies in adults with CF, which also report airway microbial community stability
despite mild, intermittent, perturbations in relation to antibiotic treatment (Fodor et al., 2012a;
Franziska Anne Stressmann et al., 2012; Zhao et al., 2012). Antibiotics have shown varying
degrees of effect on the microbiome, from very little sustained effect (Fodor et al., 2012a;
Franziska Anne Stressmann et al., 2012) to more pronounced changes in diversity, especially
when controlling for age and lung function (Zhao et al., 2012). A recent study showed that the
total antibiotic dose and proximity to the time of sampling were most predictive of community
change (Zhao et al., 2014).
As the effect of treatment antibiotics on reducing alpha diversity is expected, we looked
further into the effect of maintenance antibiotics on alpha diversity and community composition.
Similar to previous findings in the field that the majority taxonomic effect of maintenance antibiotic
use is on off-target taxa(Heirali et al., 2019; Nelson et al., 2020), we find that azithromycin use is
primarily associated with reductions in the abundance of anaerobic taxa that are often considered
commensal, and tobramycin use actually shows an enrichment of the Staphylococcus and
Stenotrophomonas genera (Fig 2.2C;2.3C-D). However, a unique finding in this study is that of a
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threshold lung function below which antibiotics do not seem to affect the alpha diversity of the
samples (Fig 2.2B). This might suggest that by the time disease has progressed to a later stage,
the microbes that have been under prolonged exposure to antibiotics have grown resistant to the
effect of antibiotics. It is also possible that there are strain level differences that are not being
captured, or that continued antibiotic use affected all susceptible bacteria, leaving a niche for
resistant bacteria to colonize.
At lower lung functions we find that the canonical CF pathogens like Staphylococcus,
Pseudomonas and Stenotrophomonas (Brooke, 2012; Wieneke et al., 2021; Winstanley et al.,
2016) are enriched in our cohort (Fig 2.1F). Even though this analysis has shown some modest
enrichment of Prevotella at lower lung function, we do not find any changes in the relative
abundance of Prevotella in samples across lung function (Fig 2.1G). This is concordant with
previous findings that Prevotella is abundant in patients across lung disease severity
(Cuthbertson et al., 2020). In our cohort, Streptococcus and Prevotella are the most commonly
observed dominant taxa in samples that have high alpha diversity. We show using the transition
dynamics of the dominant taxon in samples that Streptococcus dominated samples were in the
most stable state, that is they stayed Streptococcus dominant at the next timepoint 60% of the
time. Meanwhile Prevotella dominant samples will more frequently switch its dominant taxon at
next sampling. However, we found no strong evidence to suggest that a change in dominant
taxon was predictive of a switch to an exacerbation clinical state at next timepoint. Taken
together with our finding that alpha and beta diversity do not significantly change from baseline to
exacerbation, this suggests an overall stability in the microbiome despite clinical transition from a
baseline to an exacerbation state.
Pseudomonas aeruginosa is a major cause of chronic lung infections in CF patients and
cause for significant morbidity including a worse baseline lung function, worse radiographic and
symptom scores and worse nutritional status (Parkins et al., 2018). As such, we have clustered
our Pseudomonas dominant samples using PAM clustering and found three different
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Pseudomonas community types, two that are dominant for Pseudomonas with very few other
taxa found in high relative abundance and one that is enriched in Pseudomonas and various
other anaerobes (Fig 2.6). Despite, previous findings that P. aeruginosa presence is associated
with lower FEV1%, (Emerson et al., 2002; John et al., 2021; Paganin et al., 2015) we did not find
our Pseudomonas dominant clusters to be significantly corelated with age or lung function. This
might partly be due to our analysis being done at the level of the genus, and only a limited
number of samples that are Pseudomonas dominant at lower lung function. However, similar to
previous findings that communities with P. aeruginosa lacked members of the family
Pasteurellaceae, which includes the early CF pathogen Haemophilus influenzae (Klepac-Ceraj et
al., 2010; Watts et al., 2021) we find that the genus Pseudomonas had significantly higher relative
abundances in samples negative for Haemophilus. Pseudomonas also had higher relative
abundance in samples negative for Prevotella and Streptococcus. However, in samples where
they co-occur only Haemophilus was found to be negatively correlated with Pseudomonas. This
might be suggestive of a direct effect of Haemophilus and Pseudomonas on each other in the
polymicrobial environment but might also just be reflective of changing community composition
across age or disease stages as Haemophilus is an early CF pathogen and Pseudomonas is
more associated with advanced years and later stage disease.
One major limitations of our study is that the majority of samples used in our analysis are
OP swabs, which may not be representative of the bacterial community in the lower respiratory
tract as well as BAL or sputum samples (Goddard et al., 2012), although some authors have
shown concordance between OP swabs and BAL samples (Klepac-Ceraj et al., 2010).
Discordance between different sample types is particularly limiting in our ability to study the lower
respiratory tract of young children who do not produce sputum, since OP swabs are the
predominant means of respiratory sampling in this demographic. Since we collected all three OP
swabs, sputum and BAL samples, we were able to make some comparisons between the
community distance of different samples types. We saw differences in the UniFrac distances
between swab and sputum samples with the former being much more diverse than the latter.
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However, in paired swab-sputum samples, that is samples taken on the same day from the same
patient, we saw significantly less difference, suggesting that for intra-patient sampling and
longitudinal analysis, OP swabs may be adequate to serve as a proxy for the lower respiratory
tract. Furthermore, as patients on CFTR corrector therapy produce significantly less sputum,
understanding microbiota patterns in OP swabs may become more and more important.
While longitudinal studies enable us to characterize the microbiome and follow changes
and trends in community structure and composition over time and disease progressions, there
are limitations to the 16S based sequencing approach. In addition to leaving out the nonbacterial components of the polymicrobial environment of the CF lung, which have been shown to
be important in CF disease progression (Blanchard & Waters, 2019), it is also limited in its ability
to resolve bacterial classification to the species level. In periodontitis, where the
microenvironment between disease and healthy states often show few community differences at
the genus level, there are species within those genera that specifically correlate to disease (J.
Wang et al., 2013; Yifei Zhang et al., 2019). Similarly, as we notice relative stability in the
community microenvironment in CF samples, species specific resolution can help settle the
debate on the role of some genera in CF that can be predominant in samples with no clear
association with disease severity like Rothia, Prevotella, Streptococcus etc.
The data presented here suggest that community changes in the microbiome can be
completely different across different clinical stages but the change in dominant taxon is not
reflective of changing from baseline to exacerbation clinical status. This suggests that if changes
in the microbiome are responsible for pulmonary exacerbations, then they are either subtle or are
due to properties that cannot be measured by 16S rRNA analysis. For instance, it is possible that
a change in the clinical status is, in fact, due to a change in metabolic state or the production of
specific virulence factors in the microbial community. It is also possible that organisms that do
not have 16S like viruses and fungi are initiating the exacerbation. Metagenomic,
metatranscriptomic and metabolomic study designs can help us elucidate these types of
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relationships better and allow us to more holistically observe the microenvironment of the CF
lung.
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3

CHAPTER 3: COMPARATIVE GENOMICS OF THE HUMAN COMMENSAL
PREVOTELLA INCLUDING CYSTIC FIBROSIS ISOLATES

This chapter contains unpublished data from a manuscript in prep by Prioty F. Sarwar, Mitchell I.
Harmatz, Ahmed Moustafa, Christopher Johnston, Gisli Einarrsen, Michael Tunney, Paul J.
Planet

3.1 Abstract
The accumulation of viscous mucus in the CF lung results in a hypoxic microenvironment
permissive for the growth of obligate anaerobes. The genus Prevotella, consisting of gramnegative anaerobes, is often found in high abundance in the dysbiotic CF lung environment. In
fact, Prevotella is often part of a core CF lung microbiome, consistent across age and disease
stages. The role of Prevotella species in CF disease progression is currently unclear, due to
association of this genus both with more diverse microbiomes and relative health but also
progressed disease. Despite the frequent association of Prevotella with dysbiotic CF lung
microbiomes not much is known about this genus on the genomic level. A few comparative
studies have explored species and genus level of diversity of Prevotella along with how gene
profiles may relate to metabolism, virulence, and colonization of the host niche. We have
undertaken a pan-genome analysis of 205 Prevotella genomes to determine the overall
phylogenetic structure of the genus, leveraging a collection of 114 clinical strains from CF and
other diseases. The majority of CF isolates fall into three species: P. melaninogenica, P. histicola
and P. jejuni. We performed a GWAS analysis to identify genes and genomic features specific to
these three species and our CF isolates. We also identified putative plasmids encoded by
Prevotella genomes. We computed the mutation and recombination rates of our three target
species and provide evidence of multiple restriction modification systems that may have
contributed to low levels of inferred horizontal gene transfer. Identifying and defining the
characteristics of specific Prevotella species associated with CF disease progression can provide
more direction in the debate of the role of Prevotella in CF.
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3.2 Introduction
Members of the genus Prevotella are gram-negative anaerobes of the Bacteroidetes
phylum that are common commensals of humans. While the earlier identified Prevotella species
were largely associated with the oral cavity (Shah & Collins, 1990a) focused on studying
oropharyngeal isolates in the context of periodontal diseases, the clinical importance of Prevotella
species at other anatomic sites like the gastrointestinal and urogenital tracts have also been
known (Finegold, 1995). A central role of this genus in the healthy human gut microbiome has
been highlighted by recent culture independent microbiome studies (Ley, 2016a; Onderdonk et
al., 2016b; Shah & Collins, 1990a) where Prevotella copri in the gut has been associated with a
plant-rich, high fiber diet(Kovatcheva-Datchary et al., 2015; Ley, 2016b; Tett et al., 2019).
However, microbiome and other metagenomic studies have also highlighted the role of
the genus Prevotella in dysbiotic microbiomes associated with disease. For instance, Prevotella
abundance is found to be modulated in various chronic inflammatory conditions. For many
chronic inflammatory conditions like periodontitis, rheumatoid arthritis, bacterial vaginosis (BV)
and cystic fibrosis (CF) Prevotella can be found in high abundance at the salient anatomic site,
but also may show decreased abundance for other conditions like asthma or chronic pulmonary
obstruction (COPD) (Coburn et al., 2015; Engel et al., 2017; Hilty et al., 2010; Larsen, 2017).
One of the strongest associations with disease that Prevotella has is with periodontal disease
(Takahashi, 2015; Teles et al., 2013; Yamashita & Takeshita, 2017), where various
oropharyngeal Prevotella species strongly associate with keystone disease taxa such as
Porphorymonas gingivalis and Tannerella forsythia suggesting that they contribute to
inflammation and disease progression (Yifei Zhang et al., 2017, 2019). On the topic of
inflammatory conditions, P. bivia, P. disiens and P. melaninogenica have been associated with
BV during which a shift in microbial ecology from a Lactobacillus dominant community to a more
diverse, and Prevotella replete, vaginal microbiome is associated with disease. Importantly,
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vaginal P. bivia and P. melaninogenica were identified as associated with an increased risk of
HIV acquisition (Gosmann et al., 2017; Onderdonk et al., 2016b; Randis & Ratner, 2019).
Cystic fibrosis (CF) is a multisystem genetic disease caused by defects in the cystic
fibrosis transmembrane conductance regulator (CFTR) protein responsible for homeostasis of
chloride and sodium ions in the cell. This defect leads the production and accumulation of
viscous mucus in the lungs, creating a niche not available in healthy lungs for the replication and
outgrowth of various microbes. In particular, the viscous mucus provides hypoxic
microenvironments permissive for the growth of obligate anaerobes (Dickson & Huffnagle, 2015).
This results in the persistence of Prevotella species in high abundance in CF lungs, an
environment where the bacterial burden is kept low in healthy individuals. In fact, Prevotella is
often part of a core CF lung microbiome, consistent across age and disease stages (Hauser et
al., 2014b; Sherrard, Bell, et al., 2016; Su & Hassett, 2012). Despite the pervasiveness of
Prevotella in the CF lung microbiome, its role in CF disease progression is currently unclear, with
some studies associating the presence of this genus with more diverse CF lung microbiomes and
relative health (Laguna et al., 2016; Muhlebach et al., 2018; Edith T Zemanick et al., 2013, 2017).
Other publications suggest that members of Prevotella are more prevalent in disease than
previously appreciated and that they contribute to the production of short chain fatty acids and
chronic inflammation in the CF lung (Field et al., 2010; Mirković et al., 2015; Ulrich et al., 2010)
and may pave the way for later pathogens.(Khanolkar et al., 2020)
Despite the frequent association of Prevotella with dysbiotic microbiomes and their
complex role in health and disease, not much is known about this genus on the genomic level,
although a few recent comparative studies have explored species and genus level diversity along
with how gene profiles may relate to metabolism, virulence, and colonization of the host niche
(Fehlner-Peach et al., 2019a; Gupta et al., 2015; Tett et al., 2019, 2021). Because different
species and even strains may have vastly different roles in health and disease, it is critical to
understand genomic and species diversity to determine associations and mechanisms of disease.
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In the present study, we aimed to understand the genomic diversity of Prevotella species
in cystic fibrosis. We first undertake a pan-genome analysis of 205 Prevotella genomes to
determine the overall phylogenetic structure of the genus, leveraging a collection of 88 clinical
strains from CF and 26 clinical strains from other diseases. We present a detailed phylogenomic
analysis of Prevotella melaninogenica and its close relatives, as this is one of the most prevalent
species isolated from CF patients (Field et al., 2010; Gilpin et al., 2017). We show that P.
melaninogenica can be more accurately thought of as a “complex” composed of at least 3 closely
related species that vary in their genomic composition and chromosomal structures. To
investigate how the P. melaninogenica complex might maintain high genomic heterogeneity, we
calculated the recombination over mutation rates (R/θ) and provide evidence of a large number of
restriction modification systems that influence how much horizontal gene transfer occurs within
the species and the genus as a whole

2.3 Methods
2.3.1 Bacterial Strains and Isolation
Isolates used in this study include: 1) several type strains from NCBI GenBank; 2) CF
clinical isolates obtained by Dr. Paul J. Planet (P.J.P.) at from the cystic fibrosis center at
Children’s Hospital of New York, Columbia University, New York; CF and non-CF clinical and
commensal isolates from 3) Dr. Floyd Dewhirst and Dr. Christopher Johnston at the Forsyth
Institute in Massachusetts, United States (available in GenBank) and 4) isolates from Dr. Michael
Tunney at the Queen’s University of Belfast (not yet released) in Belfast, Northern Ireland. To
distinguish the isolation location for the genomes from three institutions their genomes have been
tagged with the suffix CU_NY, FI_MA and QUB_NI for isolates from Columbia, Forsyth and
Queens University respectively. Additionally, we obtained the Prevotella spp. 361B ATCC
700524 genome (referred to as P allisoniae 361B in this chapter) from ATCC and the assembled
and circularized Prevotella spp., 361B genome was received from Dr. Joshua Chang Mell from
Drexel University (not yet released).
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CF isolates of Prevotella from P.J.P were cultured from primary sputum or oral swabs
onto Laked Brucella Blood Agar with Kanamycin and Vancomycin selection plates in anaerobic
conditions at 37°C and validated using 16S colony PCR using the primers 519R (5’-3’:
GWATTACCGCGGCKGCTG) and 357F (5’-3’: CTCCTACGGGAGGCAGCAG). Genomic
extraction of Prevotella was done using the Promega Wizard® DNA Extraction kit according to
manufacturer’s instructions.
2.3.2 Whole Genome Sequencing, Assembly and Annotation
Isolates from Forsyth and Drexel were sequenced using PacBio SMRT long read
sequencing. Extracted gDNA of the isolates from Columbia University and Queens University of
Belfast were sequenced using the Illumina HiSeq 2500 platform. Sequencing adapters and lowquality ends with a PHRED score less than 15 were trimmed using Trim Galore! v0.6.4(Felix
Krueger, n.d.; Marcel, 2011). Trimmed reads were assembled using SPAdes v3.11.1 with default
settings for Illumina paired end reads. All assembled isolates were annotated using Prokka
v1.14.6 (Seemann, 2014) using the following options: $--kingdom Bacteria --genus Prevotella.
Sequencing contamination was determined using Mash v2.2 (Ondov et al., 2016, 2019). The
average nucleotide identity (ANI) was calculated for all species in Clade A relative to each other
using fastANI (Jain et al., 2018) and the heatmap visualized using the tidyverse and reshape2
packages in R.
2.3.3 Gene Orthology and Gene Presence/Absence Matrix
Orthologous gene sets were determined from 76 NCBI assembled Prevotella genomes
and 2 outgroups, Bacteroides fragilis (Accession number: GCA_000025985.1) and
Porphorymonas gingivalis (Accession number: GCA_000010505.1), using a modified OrthologID
(Chiu et al., 2006) pipeline that uses OrthoMCL (L. Li et al., 2003) for gene family clustering.
Matrix construction by OrthologID was limited to ortholog groups shared by at least 90% of the
taxa. A maximum likelihood phylogenetic tree was then constructed using RaxML v8.0.26 using
the model PROTCATJTTF with a final GAMMA optimization [call: -T 16 -m PROTCATJTTF -f d -
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N 1 -s matrix_70plus.phy -n best -p 1977] and 100 bootstrap iterations. Ancestral reconstruction
by unordered parsimony of the body site of isolation of representative Prevotella genomes was
done using Mesquite v3.61.
Pangenome analysis of all 205 Prevotella isolates and the subset of Prevotella Clade A
was done using ROARY 3.13.0 at 70% identity and 80% identity respectively. Using the -e option
in ROARY, a multiFASTA alignment of core genes using PRANK was created. The binary gene
presence and absence newick tree output from ROARY was visualized using iTOL (Letunic &
Bork, 2006) v6.5.2 (https://itol.embl.de/). The core genome alignment from ROARY was
reconstructed to an approximately maximum likelihood tree using FastTree (Price et al., 2010)
v2.1.10. This tree was then used as the starting seed tree for 100 RaxML v8.0.26 bootstraps
using the GTRGAMMA model [call: -T 8 -m GTRGAMMA -N 100 -s core_gene_alignment.aln -n
boots -p 1977 -b 1977] and visualized using iTOL v6.5.2.
2.3.4 16S rRNA gene alignments
A local blast database of all the Prevotella contigs was made from concatenating the
Prokka outputs of all Prevotella genomes of interest using the makeblastdb function of the NCBI
BLAST+ suite (Camacho et al., 2009) v2.12.0. The whole 16S gene, the V1-V3 region as would
be amplified by the primers 27F (5’-3’: AGAGTTTGATCNTGGCTCAG) and 519R (5’-3’:
GTNTTACNGCGGCKGCTG) and the V4 region as would be amplified by the primers 515F (5’-3’:
GTGCCAGCMGCCGCGGTAA) and 806R (5’-3’: GGACTACHVGGGTWTCTAAT) was extracted
from the database using the blastn function and a query sequence of the Prevotella albensis 16S
rRNA at 80% identity and 80% coverage. The sequences were aligned using MAFFT (Katoh et
al., 2002) v7.271 with the flags --auto –reorder and the phylogenetic reconstruction was done
using RaxML v8.0.26 GTRGAMMA model and 100 bootstrap iterations (call: -T 8 -m
GTRGAMMA -N 100 -s 16S_V4_dec.aln -n boots -p 1977 -b 1977). The resulting trees were
visualized using iTOL v6.5.2.
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2.3.5 Recombination Rate Calculation and Chromosomal Comparisons
Single nucleotide polymorphisms (SNPs) were identified in trimmed sequencing reads or
assemblies from NCBI with Snippy (Seemann, 2015) v4.4.5 by generating a whole genome
alignment against several specified reference genomes (Table 4). A phylogenetic tree of the
whole genome alignment from Snippy v4.4.5 with 100 bootstrap iterations was inferred using
RaxML v8.0.26 [call: -T 8 -m GTRGAMMA -f d -N 1 -s clean.full.aln -n reference -p 1977 ]. The
recombination rate over mutation rate (R/θ) value was calculated using the best maximum
likelihood tree from RaxML v8.0.26 and the whole genome alignment from Snippy v4.4.5 in
ClonalFrameML(Didelot & Wilson, 2015) v1.12.
Chromosomal comparisons were made using circularized PacBio genomes in Proksee
(Grant & Stothard, 2008) (https://proksee.ca/about) using their CGView Builder, GC Skew and
BLAST functions. Identification and visualization of genomic islands was done using
IslandViewer4 (Bertelli et al., 2017) (https://www.pathogenomics.sfu.ca/islandviewer/browse/).
IslandViewer4 is a composite visualization tool that allows for the visualization of genomic islands
(GIs) as predicted by four different prediction methods: 1) IslandPick(Langille et al., 2008) 2)
SIGI-HMM (Waack et al., 2006) 3) IslandPath-DIMOB (Hsiao et al., 2003) 4) Islander (Hudson et
al., 2015)
2.3.6 Identification of Prevotella 361B methyltransferases
The curated restriction enzyme database REBASE (Roberts et al., 2015)
(http://rebase.neb.com) was used to look at the methylation signatures from Prevotella 361B
(http://rebase.neb.com/cgi-bin/pacbioget?43043+e) and the P. melaninogenica FDAARGOS_306
which is also P. melaninogenica ATCC25845 (http://rebase.neb.com/cgi-bin/pacbioget?25014).
REBASE uses sequence similarity, empirical data, and the presence and order of genetic motifs
in conjunction with GenBank to detect methyltransferase systems in genomes. A local blast
database of all the predicted Prevotella proteins was made from concatenating the Prokka
outputs of all Prevotella genomes of interest using the makeblastdb function of the NCBI BLAST+
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suite v2.12.0. Each of the four predicted methyltransferase from Prevotella 361B was extracted
from the database using the blastp function at 99% query coverage and 75% identity. The
Prevotella gene presence and absence tree was annotated with the results using iTOL v6.5.2.
2.3.7 Identification of Plasmid Replication Initiation Proteins
We identified 10 replication initiation proteins from 8 plasmids of closed whole genomes
of Prevotella from Clade A (Table 7). We then classified these proteins into 3 major types MARP,
MART and MQEK based on overall sequence similarity and named for the first 4 amino acids of
the protein sequences. One representative sequence from each type was used as the query
sequence with the blastp feature to blast our local Prevotella BLAST database and extract
sequences with >90% coverage and >80% identity from our genomes. The Prevotella Clade A
core genome tree was annotated with the BLAST results in Annotation of the results was done
using iTOL v6.5.2.
2.3.8 Genome Wide Association Analysis
Scoary (Brynildsrud et al., 2016) v.1.6.16 is a downstream program to ROARY that performs
genome wide association analysis based on the gene presence absence matrix and accounting
for population stratification. Scoary uses user-defined traits and the clustered proteins ROARY
output as inputs for the analysis. We defined the following traits to find uniquely associated
genes with this phenotype: 1) P. melaninogenica complex 2) P. melaninogenica sensu stricto 3)
P. histicola 4) P. jejuni and 5) CF Clinical Isolates. For identification of hypothetical proteins we
used the query_pan_genome feature from ROARY to extract the genes from the clustered
proteins output and used the online NCBI blastp tool (https://blast.ncbi.nlm.nih.gov/) to find
closely related hits.
2.3.9 Screens for CF Specific Alleles
We identified 64 genes of interest from published Pseudomonas genes that are mutated in
chronic CF infection(Marvig et al., 2015; Winstanley et al., 2016). We first identified a Prevotella
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homolog of each gene using the online NCBI blastp tool. The Prevotella homolog was used as
the query sequence to probe our local Prevotella BLAST database with the blastp feature for
sequences from both our CF and non-CF genomes. For the BLAST results with a query
coverage above 25%, we utilized WhatsGNU(Moustafa & Planet, 2020) v1.0 to test the novelty of
that allele against a Prevotella WhatsGNU database. WhatsGNU v1.0 utilizes the natural allelic
variation in public databases to rank protein sequences based on the number of observed exact
protein matches in all known genomes of a particular species. and assigns it a novelty score (the
GNU score).
To make the WhatsGNU Prevotella database we first downloaded all Prevotella genome
assemblies available on NCBI using the WhatsGNU_get_GenBank_genomes.py script and the m flag from the WhatsGNU_main.py script which uses a path to a folder with all downloaded
genomes to generate a compressed WhatsGNU database. Our database comprises of 1,033
Prevotella strains with 2,479,438 protein alleles. We then calculated the average WhatsGNU
score for alleles from CF and non-CF isolates and screened for the genes that had a lower
WhatsGNU score, that is were more novel in the CF genomes.
2.4 Results
2.4.1 Phylogenomic topology of the genus Prevotella
To elucidate the phylogeny of the genus Prevotella we used the OrthologID (Chiu et al.,
2006) tool to construct a phylogenetic matrix of concatenated amino acid sequences across 76
Prevotella species. Matrix construction was limited to ortholog groups shared by at least 90% of
the taxa. A maximum likelihood phylogenetic tree was then constructed using RaxML v8.0.26 to
infer the relatedness of the Prevotella genomes, including the Prevotella spp. 361B genome
sequenced using the PacBio platform, and two outgroup species Bacteroides fragilis and
Porphyromonas ginigivalis (Fig 3.1A). P. melaninogenica falls in a clade with P. scopos, P. fusca,
P. multiformis, P. denticola, P. veroralis and P. histicola with a 100 bootstrap value. The species
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in this clade are mostly associated with the oral cavity and will be referred to as Clade A
henceforth in this chapter.
The clade closest to Clade A in the OrthologID tree consists of P. bivia and P. amnii, two
Prevotella species associated with and generally studied in the context of bacterial vaginosis
(Onderdonk et al., 2016b; Petrina et al., 2017; Randis & Ratner, 2019). Our phylogenomic
analysis expands upon the idea, previously proposed by Gupta et al (2015), that the gene
repertoire of Prevotella species cluster by site of isolation. Ancestral reconstruction by unordered
parsimony (Fig 3.2) shows that clustering based on site of isolation occurs to some extent, as can
be seen with Clade A. However, this does not always hold true in the overall topology of the tree.
For example, P. salivae, associated with the oral cavity (Sakamoto et al., 2004) can also be found
in the same clade with P. copri, a species primarily associated with the gut (Ley, 2016b). Even
when clades are body site specific they are found interspersed with each other when looking
across the genus. Recent microbiome and metagenome studies are increasingly identifying
Prevotella species previously thought of as oropharyngeal specific in the microbiome of additional
body sites (Tett et al., 2021).
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Fig 3.1. The evolutionary divergence of Prevotella and placement of clinical and commensal isolates within the Prevotella
genus.
(A) Phylogenetic tree based on 100 maximum likelihood nonparametric bootstrap iterations of the amino acid alignment by
ortholog ID of 76 Prevotella genomes and 2 outgroup genomes. Amino acid sequences were included if they were found in more
that 90% of genomes and shared by at least 4 of the 76 taxa.* indicates 100 bootstrap value (B) Phylogenetic network based on
the binary gene presence absence matrix from ROARY. Circular track shows the following classification of the strains: 89
Prevotella genomes from NCBI (black), 88 CF clinical isolates (green), 23 non-CF clinical isolates (orange) and 5 commensal
isolates (blue).

We expanded our phylogenetic analysis with 108 clinical isolates from Northern Ireland,
New York and Massachusetts collected over time by members of our group, a convenience
sample, and built another network using a gene presence/absence matrix of the pangenome (Fig
3.1B). This pangenome tree splits the genus into two major clades, one of which is Clade A.
Clade A in this tree includes P. jejuni, a species that was not originally included in the OrthologID
analysis. Between the two tree inference methods the major groups stay relatively similar (Fig
3.1). For example, the branching topology of P. intermedia and P. nigrescens, P. bivia and P.
amnii, and P. salivae and P. copri are similar in both networks. Both networks place the
Prevotella spp. 361B strain, first sequenced for this study and currently classified as P.
melaninogenica, in a clade with the closely related P. scopos species (Downes & Wade, 2011).
The majority of our CF isolates (58/85) fall within Clade A, suggesting that species in this
clade might be more represented in the CF lung microbiome, although this may also be attributed
to our convenience sampling strategy as well. The two species in the other major clade that
contains many of the CF clinical isolates are P. salivae (11 taxa) and P. nigrescens (5 taxa) both
of which are associated with the oropharyngeal microbiome.
2.4.2 P. melaninogenica sensu stricto and its diverse species complex:
A phylogenetic network built from the core genomes of Clade A shows that Prevotella
spp. 361B is found in a clade that also includes P. melaninogenica and P. scopos clades and is
supported by 100 bootstrap values (Fig 3.2A). However, P. melaninogenica, P. scopos, and the
clade containing the 361B strain are separated by relatively longer branches. To determine
whether Prevotella spp. 361B might be considered the same species as either P. melaninogenica
or P. scopos we did a pairwise comparison of all the genomes in Clade A using fastANI and
determined their Average Nucleotide Identity (ANI). The average ANI value reported by Ciufo et
al. (2018) for two concordant genomes, that is two genomes with matching taxonomies in the
GenBank database, is 97.1% and for two discordant genomes, that is two genomes in taxonomic
disagreement is 86.3% (Ciufo et al., 2018).
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Fig 3.2. Ancestral reconstruction of Prevotella by site of isolation of each taxon.
Unordered parsimony reconstruction using representative Prevotella genomes in Mesquite
pruned from the OrthologID tree in Fig. 1
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The ANI threshold for species classification is commonly determined between 94-98%
(Ciufo et al., 2018; Kim et al., 2014; Richter & Rosselló -Mó ra, n.d.) and due to the genomic
heterogeneity within the genus Prevotella we used the lower threshold of 94% as our species
cutoff ANI value. Hence, we determined that Prevotella spp. 361B forms its own unique species
with the two commensal isolates F0091_FI_MA and F0054_FI_MA with ANI values of 96.307%
and 96.963%, respectively (Fig 3.2B). In contrast, the ANI values of Prevotella spp. 361B
compared to the P. melaninogenica type strain ATCC 25845 is 88.054%, and to P. scopos type
strain W2052 it is 87.505%.
Given that many of the described isolates in these lineages have been historically
considered to be P. melaninogenica, we suggest that all the taxa with >87% ANI value when
compared to P. melaninogenica ATCC 25845 (the type strain) should be labelled as being part of
the P. melaninogenica complex. Along with the clade containing the strain 361B, this
classification includes P. melaninogenica strain GAI07411 (90.824%) and P. scopos W2052
(88.159%) in the P. melaninogenica complex. Here we will refer to those isolates with an ANI
value >94 when compared to P. melaninogenica ATCC 25845 as P. melaninogenica sensu
stricto. We also suggest that the clade containing strain 361B could be considered a new
species, and we propose the name Prevotella allisoniae after the microbiologist Heather E.
Allison who was the first to describe the genetic basis for the hemolytic nature of this organism
(Allison & Hillman, 1997). High genomic heterogeneity within a species leading to the creation of
a species complex has already been observed in Prevotella copri, a gut associated species,
which forms four distinct clades with distinct polysaccharide utilization profiles (Fehlner-Peach et
al., 2019a; Tett et al., 2019).
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Fig 3.3. P. melaninogenica isolates form a species complex.
(A) Phylogenetic network of Clade A based on core genes identified and aligned using ROARY with minimum 80% identity.
Includes 100 maximum likelihood nonparametric bootstrap iterations from RaxML v8.2.4. (B) Heatmap based on the average
nucleotide identity (ANI) scores of Clade A relative to each other.

The P. melaninogenica complex is part of a larger clade with P. jejuni. The ANI values
comparing the P. melaninogenica type strain ATCC 25845 to the taxa in the P. jejuni clade range
from 86.359% to 86.748%, which only just misses the cut off value for the complex. The only
exception is Prev_50919_QUB_NI which is part of the P. jejuni clade but also has 87.813 ANI
with P. melaninogenica ATCC 25845. Therefore, even though we have separated P. jejuni from
the P. melaninogenica complex the two species are closely related with a recent shared common
ancestor. In contrast to P. melaninogenica, the taxa within the P. jejuni, P. denticola and P.
histicola clades can be grouped by ANI values as a single species in comparison to their
respective reference strains; P. jejuni CD3 (96.35 – 96.759%), P. denticola F0115 (97.349 –
97.876%) and P. histicola F0411. P. denticola appears to be closely related to P. mulitformis
both from the topology of the core tree, where they form a clade with a long branch length, and
ANI values in comparison to P. denticola F0115, where P. multiformis DSM 16608 has 89.551%
ANI and P. multiformis F0096_FI_MA has 89.409% ANI.
Due to the high heterogeneity within the Prevotella genus, we wanted to see how well
these species relationships would be resolved using the 16S gene. Important for microbiome
studies, 16S sequencing is one of the ways in which the ubiquity of Prevotella across various
human microbiomes has been shown. Since Prevotella is a human commensal, to understand its
role in dysbiotic microbiomes associated with disease it is important to understand which
Prevotella species is abundant in a particular cohort. We inferred the unrooted phylogenetic
networks of Prevotella using the whole 16S gene, the V1-V3 and V4 region (Fig 3.3), both regions
commonly used in 16S microbiome sequencing.
The whole 16S gene can resolve the clades of the various species in a similar way to the
core genome tree, including placing P. melaninogenica sensu stricto, P. scopos W2052 and
Prevotella spp. 361B into three separate but neighboring clades. Some notable differences with
the core genome tree include: (i) P. melaninogenica GAI07411 now branches in the middle of the
P. melaninogenica sensu stricto clade instead of as an outgroup, a pattern observed in the the
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V1-V3 and V4 region tree as well and, (ii) P. scopos W2052 and the Prevotella spp. 361B clade
no longer form a single clade.
The resolution offered by the V1-V3 and V4 region tree has more limitations. Both trees
have species clades that correspond to multiple 16S sequences, indicating a slight variation in
16S sequences even within species that group tightly together by their ANI scores like P.
histicola. Even though the trees made from the 16S variable region show more homogeneity in
the intra species sequence variation, the 26 taxa in P. melaninogenica sensu stricto group
comprises of 6 unique V1-V3 regions and 5 unique V4 regions. The only exception to this trend
is that P. denticola and P. jejuni forms one polytomous clade in the V4 tree, that is only one V4
region represents all the genomes in that species. Furthermore, there are various incidences of
taxa grouping in clades different from what is observed in both the core genome and whole 16S
tree. In the V1-V3 region tree P. denticola CRIS 18C is found in a clade with the closely related
P. multiformis species. The 361B clade forms a polytomous branch with P. scopos W2052 in the
V4 tree. The V4 tree further splits the P. jejuni clade into two branches that do not share a most
recent common ancestor. In summary, full length 16S sequences may be a reasonable way to
classify Prevotella isolates, but V1-3 and especially V4 regions might misclassify species. Thus,
for future studies assessing the role of each species in disease, full 16S sequences or other
molecular markers will need to be used.
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Fig 3.4. Unrooted phylogenetic networks based on 16S rRNA genes in Clade A.
A) Whole 16S rRNA gene (B) V1-V3 region of 16S rRNA (C) V4 region of 16S rRNA.. Multiple sequence alignment was done
using MAFFT and includes 100 maximum likelihood nonparametric bootstrap iterations from RaxML v8.2.4.

2.4.3 Genome-wide association analysis
To identify a unique gene repertoire that could distinguish the different species within
Clade A, we used Scoary which is a program that can be used downstream of the gene presence
absence analysis from ROARY. Scoary implements pairwise comparisons to find associations
between the presence of a gene and a subset of taxa defined by the user under one ‘trait’. We
defined our traits as P. melaninogenica sensu stricto, P. melaninogenica complex, P. jejuni and
P. histicola and summarized the number of genes found as unique to each trait in Table 3.1 using
different sensitivity and specificity thresholds. Sensitivity refers to the number of genomes within
the trait that are positive for the gene of interest and specificity refers to the number of genomes
outside the trait negative for the gene of interest.

Table 3.1. Summary of Scoary output using various sensitivity and specificity cut offs for
every trait tested.

Out of our four species traits, only P. histicola and P. jejuni had a set of synapomorphic
genes identified, that is genes that are both 100% sensitive and 100% specific to the trait. We
used blastp to define as many of the hypothetical proteins of the 13 synapomorphic genes
identified for P. histicola and found mostly housekeeping genes represented (Table 3.2).
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Furthermore, excluding P. histicola from our blastp analysis revealed the presence of
homologous genes in other Prevotella species at a % identity (55-69%) that falls just below the
threshold of 70% that we used to define orthologous groups in ROARY. Given that at 55-69%
identity two proteins can be defined as homologs, these genes turned out to not be unique to P.
histicola. This limits the comparisons that can be reliably made between two different species
using ortholog groups defined by ROARY, a program that is not optimized for the analysis of very
diverse sets of genomes.

Table 3.2. Summary of the blastp identification of genes synapomorphic to P. histicola by
SCOARY analysis.

Similarly, when looking at CF isolates as a trait, very few genes were identified that had
high sensitivity to being CF associated, even when they had high specificity to the CF trait. The
Scoary analysis was limited in its ability to find genes uniquely associated with CF either due to
limited power or because genes relevant in CF disease may show unique mutations instead of
being wholly absent from the genome. Since a lot of CF-associated genes found in other species
are mutated in the context of CF (Marvig et al., 2015; Melter & Radojevič, 2010; Schwartbeck et
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al., 2016; Winstanley et al., 2016), we changed our approach from gene presence and absence
associations to compare the novelty of alleles in CF vs non-CF isolates using WhatsGNU, a
compressed database approach to defining novel alleles. Our WhatsGNU search strategy,
summarized in Fig 3.4A, started with identifying 64 genes of interest in CF from the
Pseudomonas aeruginosa literature.(Marvig et al., 2015; Winstanley et al., 2016). We then used
a local protein BLAST database of 205 genomes to extract the amino acid sequences of our
genes of interest and tested those sequences against our user curated Prevotella WhatsGNU
database for allele novelty. We used all Prevotella genomic assemblies available on NCBI at the
time of analysis resulting in a database of over 2 million alleles from 1,033 Prevotella genomes.
WhatsGNU scores alleles based on their novelty in the database, with a novel allele receiving a
score of 0 and the score increasing with more allelic matches.

Fig 3.5. Screen for alleles that are more novel in CF using WhatsGNU.
(A) Schematic of screening for alleles that are more novel in CF isolates using WhatsGNU (B)
Representation histogram of one gene retS showing the distribution of GNU scores for all the
alleles extracted from our Prevotella genomes.
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Comparing the average WhatsGNU scores of alleles from CF and non-CF genomes we
identified 5 genes that had lower scores for the alleles from CF genomes: retS, wspE, mexS,
gacS, phuR. While these genes warrant further investigation in our Prevotella CF isolates, our
WhatsGNU analysis is limited by the size of our database. In comparison to our 1,033 genome
database encompassing the whole Prevotella genus, the smallest database available from the
developer is for a single species Pseudomonas aeruginosa made from 4,712 genomes and
contains 28 million+ proteins post compression. Our small database means that the WhatsGNU
scores for all our alleles are relatively low, making interpretation of the differences between the
CF and non-CF groups difficult. Most of our alleles had scores concentrated between 1-5 as
seen from the representative distribution of retS scores (Fig 3.4). Since our genomes were also
included in the database, the lowest WhatsGNU score our alleles could have gotten is 1. The two
most promising hits by the current WhatsGNU analysis are retS and gacS, both of which are
response regulators, since the difference in WhatsGNU scores between the CF and non-CF
alleles though small can be observed when comparing 200+ alleles.

Table 3.3. Summary of genes that had more novel alleles in CF genomes by our WhatsGNU
screen.

2.4.4 Species in Clade A have high recombination rates:
One of the ways for bacteria to maintain highly diverse genomes is by horizontal gene
transfer. To investigate recombination as a metric of DNA exchange in Prevotella we reported
the R/θ values, the relative rate of recombination to mutation, calculated using ClonalFrameML
for different Prevotella species summarized in Table 4. The lowest R/θ value observed in our
analysis for P. histicola is from 0.530 – 0.630 and the highest is P. jejuni from 0.817 -1.008.
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These values suggests that in P. histicola there is a little over one recombination event for every
two mutation events and in P. jejuni the ratio is closer to 1 recombination event for every 1
mutation event. This indicates a high rate of recombination within Prevotella.

Table 3.4. Recombination over mutation rates (R/θ) for various Prevotella species
calculated relative to multiple reference genomes.

In contrast, Staphylococcus aureus that has been characterized as mostly evolving
clonally, that is with restricted contribution by recombination, has a R/θ value of 0.215 reported by
Didelot and Wilson (2015) (Copin et al., 2019; Didelot & Wilson, 2015; Planet et al., 2017). The
R/θ value of our investigated Prevotella species is comparable to the high recombination rates
displayed by Pseudomonas aeruginosa with a reported R/θ = 0.54 (García-Ulloa et al., 2021).
We calculated R/θ using multiple reference genomes to account for biases caused by the
reference to which SNPs are measured. When we compare the phylogenetic networks from
Snippy’s whole genome alignments (Fig 3.5), we see that the topology of the tree is identical
across all the trees generated for P. histicola but there are subtle differences in the topology
across the trees generated for P. melaninogenica complex, suggesting that changing references
might be introducing bias in P. melaninogenica complex phylogenetic reconstruction and
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subsequent R/θ calculation. This impact is somewhat expected as we have shown that the P.
melaninogenica complex comprises of multiple species.

Fig 3.6. Phylogenetic networks based on SNP identification against different reference
genomes.
Trees generated for (A) P. melaninogenica complex and (B) P. histicola. Includes 100 maximum
likelihood nonparametric bootstrap iterations from RaxML v8.2.4.

To further investigate how the recombination affected the Prevotella genomes we
compared the chromosomes of several whole genome assemblies to the P. melaninogenica type
strain ATCC25845 (Fig 3.6). Prevotella genomes are made of two distinct chromosomes shown
by the alignment of the chromosomes to each other, where the mapping of chromosome I to II
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and vice versa resembles that of the outgroup species B. fragilis. We have labelled the major
chromosome as chromosome I and the minor chromosome as chromosome II regardless of
GenBank assigned chromosome numbers for our analysis. The mapped chromosomes visually
presents as gaps in the genomes, the genomic heterogeneity in Prevotella we have found via our
whole genome alignments, ANI and R/θ analysis. Chromosome II shows more genomic
heterogeneity than chromosome I, especially when comparing across species where the gaps in
the mapping are too frequent to distinguish any specific pattern.

Fig 3.7. Prevotella has two distinct and diverse chromosomes.
Alignment of chromosome I and chromosomeII of P melaninogenica ATCC25845 with genomes
(A) within P. melaninogenica and (B) across several Prevotella species in Clade A.
Chromosomes in the reference are aligned to the corresponding chromosomes unless otherwise
specified in the legend. * indicates gap regions containing genomic islands as predicted by
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IslandViewer6 in Fig 8. Black arrows indicate gao regions of potential recombination with P.
histicola chromosome II. Chromsome II in (B) has not been annotated due to frequency of gap
regions.
The gaps in the chromosome mapping can indicate regions that have been lost due to
some mechanism or might be indicative of regions that underwent recombination. As such, we
see the overlap of some of these gap regions with genomic islands (GIs) predicted by
IslandViewer4 (indicated with * in Fig 3.6), which can often be regions that undergo high rates of
recombination. Furthermore, when we compare the mapping of P. histicola F0411 chromosome I
and the whole genome to P. melaninogenica ATCC 25845 chromosome I, we can locate gap
regions in the chromosome I map that are filled by the whole genome map, showing the presence
of that region to be in chromosome II (indicated with black arrows on Fig 3.6). This indicates that
recombination occurs between chromosome I and II.
Since our phylogenetic analysis groups P. allisoniae 361B with P. scopos W2052 via
multiple methods (OrthologID pangenome alignment and V4 16S rRNA alignment), we wanted to
compare the mapping of the P. allisoniae 361B genome to P. scopos W2052 and the other two P.
allisoniae strains (Fig 3.7). We see that there are regions of the P. allisoniae 361B genome that
uniquely map to P. scopos W2052, that are gap regions in the maps with P. melaninogenica
ATCC25845 and the other P. allisoniae strains (indicated with black arrows on Fig 3.7). But there
are also regions that are unique to the P. allisoniae species as well (indicated with red arrows on
Fig 3.7). It is possible that the homology of the ORFs present in these regions and whether they
are part of the core or accessory genome can affect how algorithms will cluster and align the P.
allisoniae species. Despite being separate species both P. allisoniae and P. scopos are part of
the same species complex and therefore very closely related.
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Fig 3.8. Whole genome map of P. allisoniae 361B compared to whole genomes from P.
melaninogenica complex.
Red arrows indicate regions that seem unique to the P. allisoniae species. Black arrows indicate
regions that P. allisoniae 361B shares with P. scopos W2052 but not P. melaninogenica
ATCC25845 or the other P. allisoniae strains.

2.4.5 Restriction-modification systems as a potential barrier to horizontal gene transfer in
Prevotella:
One of the ways that bacteria limit horizontal gene transfer is by using restriction
modification (R-M) systems. A defense mechanism against foreign DNA, R-M systems cleave
specific sequences of double stranded DNA based on recognition sequences, known as
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restriction sites. There are four types of R-M systems: Types I-III each recognize and cut strands
that do not have methyl groups, while, in contrast, Type IV has a methyl-dependent restriction
endonuclease which cuts strands containing a methyl group. R-M systems are often specific
between species and even between strains or subspecies. Johnston et al. (2017)(Johnston et al.,
2017) found tremendous diversity in the R-M systems within Prevotella intermedia.

Fig 3.9. Genomic Islands as predicted by IslandViewer4 in representative Prevotella genomes.
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Genomic islands predicted in the chromosome I and II of (A) P. melaninogenica ATCCC25845
and (B) P. histicola F0411. Genomics islands (GIs) predicted by Islander is in light blue, SIGIHMM is in orange, IslandPath-DIMOB is in dark blue. Red indicates composite regions of GIs
predicted by multiple methods

We used REBASE, a curated genomic database that uses data generated by the PacBio
sequencing platform to identify the R-M systems in P. allisoniae 361B. REBASE identified four
active R-M systems in 361B (Fig 3.9; Table 5). One type I gamma (Psc361B1; Fig 3.9A), two
type II gamma (Psc361BII and Psc361III; Fig 3.9B-C) and one type III beta (Psc361BIV; Fig 3.9D)
R-M systems were detected. All these potential R-M systems have post-replicative modification
that result in N6-methyladenosine (m6A) epigenetic markers. Psc361BI consists of one
methyltransferase, one restriction enzyme, three specificity subunits, 3 unidentified ORFs and
corresponds to the predicted recognition sequence of CCAYN7TTC (bolded nucleic acid indicates
the site of methylation). Psc361BII has a predicted recognition sequence of TTCGAA, and
contains one restriction enzyme, one methyltransferase, one control protein, and two additional
ORFs of unknown function. Psc361BIII corresponds to the predicted sequence CTRYAG, and
contains one restriction enzyme, one methyltransferase, and two ORFs.

Fig 3.10. Schematic diagram showing restriction modifications systems of P. allisoniae
361B.
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(A) Type I gamma restriction modification system with a predicted recognition system
CCAYN7TTC. (B) Type II gamma restriction modification system with a predicted recognition
system TTCGAA. (C) Type II gamma restriction modification system with a predicted recognition
system CTRYAG. D) Type IV beta restriction modification system with a predicted recognition
system CGGTA.

Table 3.5. Summary of R-M systems predicted in P. allisoniae 361B by REBASE.
The components of the four identified R-M systems are delineated by solid horizontal black lines

Table 3.6. Summary of R-M systems predicted in P. melaninogenica FDAARGOS 306 by
REBASE.
P. melaninogenica FDAARGOS 306 is the type strain P. melaninogenica ATCC25845 sequenced
by a second group. No active R-M system has been predicted due to the lack of
methyltransferase but the components of the what would be separate R-M systems are
delineated by solid horizontal black lines
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In comparison, for P. melaninogenica FDAARGOS306, another assembly released for
the P. melaninogenica ATC25845 type strain, which is the only other genome publicly available
within the P. melaninogenica complex on REBASE, six potential restriction enzymes were found
(Table 3.6). However, REBASE did not predict a methyltransferase gene for these, and four of
these systems did not have a corresponding predicted recognition sequence. Thus, there was
insufficient evidence to conclude that these genes were part of a functional R-M system. There
are multiple type I and II R-M systems predicted in P. melaninogenica FDAARGOS_306 and P.
allisoniae 361B. However, despite the overlap in the R-M system subtypes found between the
two genomes, there were no overlapping systems or shared predicted recognition sequences
between them. The diversity of components within these systems suggests that Prevotella
isolates, even from the same or closely related species, can have a large heterogeneity in their RM systems.
To further investigate potential overlap in R-M systems across the genus in silico we
searched for the presence of the four active methyltransferases from P. allisoniae 361B in all our
Prevotella genomes and found no predictable distribution (Fig 3.10) of the methyltransferases.
No other taxon contained all four methyltransferases suggesting that P. allisoniae 361B cannot
freely exchange exogenous DNA with any other isolate on the tree. All four methyltransferases
could be found distributed across the tree. The type I gamma methyltransferase Psc361B1 is
found most frequently and appears to be concentrated in Clade A. The two type II gamma
methyltransferases were the least frequently found appearing in only three other taxa. The
distribution of the methyltransferases suggests that it might be possible for P. allisoniae 361B to
exchange exogenous DNA with very distantly related species but not with some of the species
that are closer relatives. R-M systems generally provide barriers to DNA exchange, and, at least
with these two examples, this distribution is aligned with the genetic diversity that we find within
the Prevotella melaninogenica complex.
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Fig 3.11. Distribution of methyltransferases identified in P. allisoniae 361B across the
Prevotella genus does not show species specificity.
Presence of the four methyltrasnferaes in P. allisoniae as identified by REBASE mapped onto the
ROARY gene presence and absence tree from Fig 1.

2.4.6 Other mechanisms of HGT in Prevotella
To further investigate mechanisms of horizontal gene transfer in Prevotella, we examined
8 previously identified plasmids in Prevotella genomes available from NCBI genbank (Table 3.7),
using blastp to determine the genes present on each plasmid. From the eight plasmids, 10
separate replication initiation proteins were identified. Using the blastp feature from NCBI, we
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compared each of the 10 replication initiation proteins and found that they could be classified into
3 unique categories, named for the first four amino acids in their sequences: MART, MARP, and
MQEK. Comparing MART to MARP, the maximum amino acid %identity between two sequences
was 76% but only over 13% query coverage. The maximum query coverage between these
groups was 51%, but then the %identity fell to 69.55%. MQEK when compared to either MART
or MARP was unable to find enough sequence similarity to produce an alignment. We then
performed BLAST using these sequences against our local BLAST database of Prevotella
genomes, selecting for genes with a percent coverage over 90% and a %identity over 80%.
Matches within each genome are annotated in Fig 3.3A. Multiple instances of each replication
initiation protein were found in both closely and distantly related genomes, indicating that the
presence of these replication initiation proteins is distributed and commonly found within Clade A.
However, we were unable to determine whether these are part of true plasmids or integrated into
the genome and cannot infer how much they contribute to HGT in Prevotella. Furthermore, the
GIs predicted by IslandViewer4 contains multiple ORFs that might contribute to HGT within
Prevotella like Cas9 proteins, transposases and conjugative transposon proteins from the tra
family of genes.

Table 3.7. The 10 replication initiation proteins used to identify the three broad groups
MART, MARP and MQEK to classify replication initiation proteins in the Prevotella Clade A.
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3.5 Discussion
Despite frequent associations with the microbiomes of chronic inflammatory diseases, the
potential pathogenic role of Prevotella in the dysbiotic microbiome of disease states is often
contested due to its commensalism of healthy human microbiome and frequent contradictory
associations with states of both health and disease (Tett et al., 2021). We have shown here the
genomic diversity in the primarily oropharyngeal associated Clade A, especially the species P.
melaninogenica. Our work shows that many isolates that we thought of as being P.
melaninogenica, group as separate species according to their ANI scores. Therefore, grouping
them together as part of a complex can preserve the previous idea of thinking of them as one
species while allowing for their delineation when necessary for their functional characterization
during disease. Literature on the genomic diversity in P. copri reach similar conclusions, that
there is a need to think about P. copri as a complex of separate species since they have distinct
polysaccharide utilization profiles and differences in metabolism might be driving differences in
health outcomes (Y. Li et al., 2021; Metwaly & Haller, 2019). We hypothesize that, similar to P.
copri, the role of P. melaninogenica in disease will be easier to elucidate once we start
differentiating its prevalence according to the separate species in the complex.
Due to our finding that 16S variable regions might not be sufficient to resolve the P.
melaninogenica complex along with other species like P. jejuni, P. multiformis and P. denticola,
the proposed next step to elucidating strain-level differences in P. melaninogenica is via shotgun
metagenomic sampling of the CF microbiome. Shotgun metagenomic sampling will be beneficial
in elucidating the role of not just specific Prevotella species in CF but also the many other
anaerobic species that are prevalent in CF. Network level analysis of the microbiome, that takes
into account the interconnectedness of the sequenced taxa in samples, on meta-transcriptomic
sequences is already being used in the context of periodontitis to elucidate the functional role and
microbial interactions of periodontal pathogens in biofilms of the subgingival plaque (Yifei Zhang
et al., 2019). Even though respiratory metagenomic sequencing is significantly more challenging
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than in other body sites due to the low ratio of bacterial to human DNA, metagenomic probing of
the human sputum, where bacteria is more concentrated, has been successfully used to model
strain-level dynamics of P. aeruginosa variants in the CF lung (Dmitrijeva et al., 2021).
However, to move the use of shotgun metagenomics beyond just understanding the
strain-level associations of Prevotella with the CF lung and probe more into specific virulence and
metabolic factors and mutations we need to characterize the genomes of the specific Prevotella
species better. Pan genome analysis done on the genus Prevotella in general is sparse (Gupta
et al., 2015; Ibrahim et al., 2017; Olsen et al., 2017; Tett et al., 2019) and this is the first study
with a specific focus on comparative genomics of P. melaninogenica. In trying to probe deeper
into sections of the genomes that seem interesting, such as predicted genomic islands, the high
number of hypothetical proteins and uncharacterized ORFs limit the meaningful information that
can be gleaned from studying these regions using sequence alone. More groundwork is
necessary to annotate Prevotella genomes which might share homology with known proteins at
percentages below the detection of standard annotation softwares like Prokka. Furthermore, to
make the use of reference-based analysis like genome construction for metagenomically
sequenced genomes or single nucleotide polymorphism (SNP) analysis more meaningful, more
representative genomes from whole genome sequencing of Prevotella are required. We have
shown in this chapter that SNP analysis for the P. melaninogenica complex might show varied
topology based on the reference used. At the time of writing, the number of whole genome
assemblies available for P. melaninogenica in NCBI GenBank is less than 50 genomes. Some of
which, like the F0091_FI_MA and F0054_FI_MA isolates, we have shown are not P.
melaninogenica sensu stricto and therefore likely that these 50 genomes are representative of
multiple species.
Reliably characterizing the whole genome of P. melaninogenica is crucial for several
reasons. Specifically, in the context of CF where bacterial populations can persist over long
periods of time it is important to know if and how populations of P. melaninogenica might be
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mutating longitudinally. Within-host mutations that change virulence potential have been
described in the context of multiple CF pathogens like P. aeruginosa, S. aureus and NTM (nontuberculosis mycobacteria) which can result in co-existing subpopulations of the same species
and alterations in their virulence and biofilm forming potential (Evans, 2015; Kreutzfeldt et al.,
2013; Melter & Radojevič, 2010). Second, to delve further into the mechanisms of horizontal
gene transfer we need reliably sequenced whole genomes using long reads sequencing
platforms like PacBio. Long read sequencing allows for the circularization of genomes, which is
important to identify plasmids and in the case of Prevotella its two distinct chromosomes. We
show that the minor chromosome in Prevotella tends to be more heterogenous at least in the
species within Clade A, suggesting that this chromosome might be more efficiently exchanging
genetic information. To find out whether one chromosome is driving the heterogeneity in the
genus, we need to characterize the recombination rates and other mechanisms of horizontal
gene transfer like transposon elements, CRISPR-Cas9 systems and restriction modification
systems at the level of the chromosome.
There is a growing need for the strain level resolution of microbiomes as more
microbiomes are being characterized and more bacteria important in the polymicrobial style of
pathogenesis of chronic diseases defined by dysbiotic microbiomes are being characterized.
This is especially true for genera, such as Prevotella, which can be found in high relative
abundance in both health and disease contexts. The way forward to settling the debate on the
benefits or pathogenesis of Prevotella colonization of the CF lung is via characterization of the
species and the genomes associated with mild or severe CF disease.

78

3

CHAPTER 4: DISCUSSION

4.1 Data Summary
The genus Prevotella is a common part of the human microbiome both in the context of
health and disease. It is a commensal of the microbiome at various anatomic sites but is also
found in high abundance in the dysbiotic communities of chronic inflammatory diseases (Tett et
al., 2021). Prevotella comprises of a very diverse group of species with varied metabolic activity
and immunomodulatory potentials (Avguštin et al., 1997; Fehlner-Peach et al., 2019a; Larsen,
2017). Prevotella is found frequently and in high relative abundance in the CF lung microbiome
across all ages and disease stages (Coburn et al., 2015). The lack of a clear association with
severe disease and its presence in the more diverse CF lung microbiomes associated with better
health outcomes (Cuthbertson et al., 2020) means that the pathogenic potential of Prevotella in
the CF lung is still contested. Additionally, Prevotella is difficult to culture out of the lungs and the
standard clinical practice to identify CF infections via culturing means that the field has been
focused on understanding the pathogenic role of more easily culturable bacteria, leaving the role
of anaerobes in CF relatively understudied.
Due to the heterogeneity of the Prevotella genome and the demonstrated variation of the
effect it can have in the dysbiotic microenvironment of various bodysites, we hypothesized that
the key to understanding the role of Prevotella in CF is to study Prevotella at the species level.
Hence, I have focused my work on P. melaninogenica due to its frequent isolation from the CF
lung and its association with poorer oral health outcomes in the context of periodontal diseases
(Yamashita & Takeshita, 2017). In this thesis, I show that there is a large amount of genomic
heterogeneity within the P. melaninogenica species. Acknowledging this diversity and designing
studies to capture the strain level diversity of the Prevotella in CF lungs might be the key to
understanding how Prevotella can be meaningfully associated with outcomes of both health and
disease during CF.
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In chapter 1 we characterize the ecology of the largest prospective pediatric CF cohort to
date. Our findings reflect a lot of what is known from the literature about the ecology of the CF
lung. We find an association of a diverse microbial lung environment with higher lung function
and a drop in microbial diversity during both acute antibiotic treatment for pulmonary
exacerbations and because of long-term maintenance antibiotics (Fig 2.1A-C). We also showed
that there is a threshold lung function below which inhaled antibiotics do not have any significant
effect on the overall alpha diversity of samples, suggesting that perturbations in the lung
microbiome by antibiotics at later stage disease might be limited (Fig 2.2B-C).
In our cohort, Prevotella seems to be slightly associated with lower lung functions (<80
FEV1%) but its relative abundance stays relatively steady across mild to severe lung disease (Fig
2.1F-G). Prevotella and Streptococcus are also often the dominant taxa in more diverse samples
(Fig 4) but while Streptococcus dominance correspondeds to a steady state of samples where
~60% of samples at next time point were also Streptococcus dominant, Prevotella dominant
samples transitioned to a sample dominant for a different taxon ~70% of the time (Fig 2.9).
These findings set up a framework for the role of Prevotella in CF disease progression, in that it is
a steady part of the CF microbiome but also could be part of dynamic microbiome composition.
We further study the potential for Prevotella to cause CF disease progression by doing a
comparative genomic analysis using Prevotella CF isolates in chapter 3.
Chapter 3 explores the genetic diversity within the genus Prevotella particularly focusing
on the clade that contains P. melaninogenica and its closely related species. We identify a clade
(Clade A) that might be more prevalent in CF lungs and show that P. melaninogenica is a
complex of multiple species. The species level resolution of these isolates by 16S variable
regions is somewhat limited which means associations found by microbiome studies where
samples were sequenced using a limited number of 16S variable regions might be confounded by
multiple species being represented as a single taxon. Our calculated R/θ values, which is a
measurement of recombination, shows that Prevotella species have high recombination rate that
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likely contributes to its genetic diversity. However, when we look at the R-M systems in our P.
allisoniae 361B strain we find 4 distinct and active R-M systems. Furthermore, the
methyltransferases of this strain are sporadically distributed across the genus indicating
significant barriers to DNA exchange between 361B and other Prevotella spp. strains all of which
likely have their own unique R-M systems as well. Hence, we can see that despite high
recombination there are significant barriers to DNA exchange within this genus as well. The
interplay of different mechanisms of horizontal gene transfer (HGT) likely contribute to the overall
maintenance of this diverse genus.

4.2 Future Directions
The potential pathogenic role of Prevotella in dysbiotic microbiomes is contested despite
frequent associations with disease and its immunomodulatory and complex metabolic properties
because it is a common human commensal and therefore easy to dismiss as something we might
see in dysbiotic microbiomes. But the frequency and abundance with which Prevotella is found in
dysbiotic microbiomes associated with disease makes it an important group of bacteria to study
further in the context of disease. The diversity within this genus makes it a difficult bacteria to
associate reliably with the microbiome at the genus level. However, this is not a unique challenge
since Staphylococcus is also a genus that cannot be studied at the species level using 16S rRNA
profiling but comprises of species that can be highly pathogenic like Staphylococcus aureus or
more mutualistic like Staphylococcus epididermis.
The fact that Prevotella melaninogenica comprises of closely related species that make
up a species complex and the evidence of strain specific functional profiles and strain specific
HGT mechanisms suggests that the key to understanding the role of Prevotella in CF, in fact, in
any chronic inflammatory disease, is by studying this genus at the species and/or strain level.
The following are some ways in which we can leverage this strain-specific study approach to
elucidate the role of Prevotella in health and disease.
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4.2.1 Species Specific Resolution of Microbiomes using Metagenomics
We have shown in chapter 3 the genomic diversity in the primarily oropharyngeal
associated Clade A, especially the species P. melaninogenica, which we defined as a complex of
four different species. This is the first work showing the extent of genomic diversity within P.
melaninogenica and this knowledge should be used as a starting point to design studies that take
into consideration this diversity. Studies on genomic diversity in P. copri have reached similar
conclusions, that there is a need to think about P. copri as a complex of separate species since
they have distinct polysaccharide utilization profiles and differences in metabolism might be
driving differences in health outcomes (Y. Li et al., 2021; Metwaly & Haller, 2019). We
hypothesize that, similar to P. copri, the role of P. melaninogenica in disease will be easier to
elucidate once we start differentiating its prevalence according to the separate species in the
complex.
Due to our finding that several 16S variable regions might not be sufficient to resolve the
P. melaninogenica complex and other species associated with the oropharynx of both disease
and health like P. jejuni, P. multiformis and P. denticola, the proposed next step to elucidating
strain-level differences in P. melaninogenica is via shotgun metagenomic sampling of the CF
microbiome. Since shotgun metagenomics is limited in studying respiratory samples due to the
low ratio of bacteria to human DNA, I will need to leverage the sputum samples from our EcoCF
collection. Sputum has a more concentrated amount of bacteria than OP swabs and has been
successfully used to model strain-level dynamics of P. aeruginosa variants in the CF lung
(Dmitrijeva et al., 2021).
However, probing the lower respiratory tract in a pediatric cohort with sputum is often not
possible because younger children cannot easily expectorate sputum. For younger or infant
cohorts it might be sufficient to probe the lung microbiome using the whole 16S rRNA gene in OP
swabs since we show that resolution of Clade A by whole 16S rRNA gene can give us similar
topology and preserve the species grouping as shown by the core genome phylogenetic tree.
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Another limitation to meaningful genome level functional or pathway analysis using
metagenomics in Prevotella is its poorly annotated genome. In trying to probe deeper into
sections of the genomes that seem interesting, such as predicted genomic islands, the high
number of hypothetical proteins and uncharacterized ORFs limit the meaningful information that
can be gleaned from studying these regions using sequence alone. More groundwork is
necessary to characterize and annotate Prevotella genomes better. One reason why annotation
software label so many ORFs as hypothetical proteins might be because the similarity of the
hypothetical protein with other known proteins fall below the detection threshold of software like
Prokka. In our work, we have been able to predict the function of many of these ORFs using
NCBI blastp.
Due to the ubiquity of Prevotella in the CF lung microbiome across mild to severe disease
it might be more beneficial to do any subsequent microbiome analysis using a network-based
analysis instead of just relative abundance or prevalence, since it considers the
interconnectedness of all the bacteria in the sample (Layeghifard et al., 2019). In chapter 2 we
find that Prevotella is differentially enriched in the microbiomes of lower lung function but can
have a relatively steady relative abundance across mild to severe disease, suggesting that
changes in the composition of other bacteria in the sample might be driving this demonstrated
‘enrichment’ of Prevotella. Studies using network-based analysis has shown that the top taxa
identified by a network based methodology and an abundance based methodology can be quite
different (Layeghifard et al., 2019).
The advantage of shotgun metagenomics are beyond just strain level resolution but can
also clarify the functional profiles of the microbiome as a whole and include organisms not
detected by 16S like fungi, which has also been shown to contribute to CF disease progression
(Blanchard & Waters, 2019; Martín-Gómez, 2020). Meta-transcriptomics can take this analysis a
step further by probing specifically the transcriptome in a microbiome allowing the analysis to
focus on genes that are actively being transcribed and at higher levels. In a polymicrobial context
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such as CF this can be particularly valuable as the metabolic profile of the microenvironment is
often a sum of the activity of many bacteria and not just one dominant one. Prevotella in CF
especially is associated with diverse microbiomes and is likely interacting with other bacterial
species. This approach has been used to elucidate the functional role and microbial interaction of
periodontal pathogens in biofilms of the respiratory tract (Yifei Zhang et al., 2019). Additionally,
shotgun metagenomic sampling will be beneficial in elucidating the role of not just specific
Prevotella species in CF but also the many other anaerobic species that are in the same situation
as simultaneously being a common commensal and enriched in the dysbiotic microbiota like
Veillonella and Rothia.
4.2.2 Whole genome sequencing (WGS) of Prevotella isolates
We show in chapter 3 that P. melaninogenica is a complex comprising of at least four
different species when comparing the average nucleotide identity (ANI) scores of all the isolates.
Furthermore, we were unable to find any strong candidates for genes in Prevotella that might be
important for CF either by comparing gene presence and absence or by comparing mutations in
alleles. Limitations to our allelic screen were several; the lack of power, the use of a database at
the genome level instead of the species level, the lack of disease severity taken into
consideration, the non-CF comparison group also contained clinical isolates from other diseases,
which might be confounding results since these isolates are neither CF associated nor associated
with health. This suggests an immediate need for more data that can make database dependent
in silico approaches like WhatsGNU a lot more effective.
Currently there are less than 50 whole genome assemblies of P. melaninogenica in NCBI
Genbank, encompassing of all the species represented by the P. melaninogenica complex. This
means that even less information is available about each. Since it is expected that every strain
will have a set of unique genes to contribute to the total pan genomes of the species in question,
only a few whole genome sequenced isolates is not enough to understand the spectrum of what
is encoded and expressed by the species. Even with over 100 isolates added to my analysis
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across the genus, my ROARY output shows that Prevotella has an ‘open pangenome’ i.e. every
new taxa added to the analysis can still contribute to gathering more information about the genus.
Closed genomes are additionally beneficial for optimizing whole genome reconstruction from
metagenomic samples or any other reference-based analysis like identifying SNPs, making any
whole genome sequencing efforts beneficial not just for the particular project it is done for but the
field in general.
The next step in this project is to isolate Prevotella colonies from the primary EcoCF
samples, which will allow for concurrent pan-genome comparative analysis and phenotypic
characterization of the Prevotella isolates that are cultured out. Given the immense diversity we
show in Prevotella and specifically Clade A in chapter 3 that it is important to sequence these
genomes using long read sequencing like the Pacbio SMRT platform. Long read sequencing
allows for the circularization of genomes, which is important to identify plasmids and in the case
of Prevotella its two distinct chromosomes. We show using chromosomal mapping of multiple
Prevotella isolates within the P. melaninogenica complex and also across the species in Clade A
that even closely related isolates within the species can show large gaps in the mapping which
corresponds to areas of predicted genomic islands (GIs).
GIs are a particularly interesting part of the genome to focus on because these regions
are thought to undergo higher rates of recombination and have a concentration of virulence and
metabolic factors and mobile genetic elements like conjugative transposons, transposases,
CRISPR-Cas9 etc. We show that distantly related Prevotella species can have similar R-M
systems and vice versa where closely related species can have no overlap in R-M systems. This
indicates that the taxa that we analysed using REBASE, P. allisoniae 361B, potentially can
exchange DNA information with species that are distantly related. Mapping the movement of GIs
across the genus will help us understand which strains have the potential for DNA transfer and
whether certain species are more likely to be able to exchange DNA with each other.
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We show that the minor chromosome in Prevotella tends to be more heterogenous, at
least in the species within Clade A, suggesting that this chromosome might be more efficiently
exchanging genetic information. To find out whether one chromosome is driving the
heterogeneity in the genus, we need to characterize the recombination rates and other mobile
genetic elements at the level of the chromosome. Understanding how a bacterium mutates is
especially important in the context of CF as one species population can persist in the lung over
long periods of time, giving the bacteria enough time to mutate under the specific stressors of the
CF lung microenvironment. Within-host mutations that change virulence potential have been
described in the context of multiple CF pathogens like P. aeruginosa, S. aureus and NTM (nontuberculosis mycobacteria) which can result in co-existing subpopulations of the same species
and alterations in their virulence and biofilm forming potential (Evans, 2015; Kreutzfeldt et al.,
2013; Melter & Radojevič, 2010). Therefore, it is important to culture and sequence Prevotella
isolates from both the spectrum of lung disease but also longitudinally to be able to see how
Prevotella populations within the CF lung can change over time.
4.2.3 Phenotypic characterization of Prevotella diversity: Prevotella cytotoxicity and
antibiotic resistance
Phenotypic diversity in the genus Prevotella has been known long before its diversity was
shown using culture-free sequencing. Phenotypic differences, in particular the ability to
breakdown certain carbohydrates over others, have caused Prevotella to be
reclassified.(Avguštin et al., 1997; Kononen et al., 1998) Furthermore, any metabolic or virulence
potential detected with sequencing technology needs to be verified phenotypically for activity as
well. In vitro analysis has also shown that Prevotella can promote P. aeruginosa survival in the
presence of antimicrobial compounds via the production of beta-lactamases.(Sherrard, Mcgrath,
et al., 2016) In particular, P. melaninogenica isolates from CF lungs have been shown to have
varied ‘resistomes’ with some isolates even being multi-drug resistance (Lamoureux et al., 2021).
The characterization of the resistome in silico can be informative in that it gives a snapshot of all
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the resistance markers encoded by the bacteria. However, for meaningful clinical associations it
is important to validate in silico findings with assays to test the activity of these encoded
resistance genes. This is particularly important for any Prevotella isolated from our EcoCF cohort
since we show in chapter 2 that Prevotella abundance is resistant to change during maintenance
antibiotic use. In fact, Prevotella is even differentially enriched in patients on tobramycin and/or
azithromycin use.
Even beyond antibiotic resistance, P. melaninogenica can secrete a number of potential
virulence factors that might contribute to tissue damage and epithelial barrier disruption (Kondo et
al., 2018). Kondo et al (2018) demonstrated in a study of proteins secreted by Prevotella an
important biological tool that will help further the understanding of the cytotoxic potential of
Prevotella – transformation of Prevotella using an E. coli shuttle vector. While they have
successfully transformed only one P. melaninogenica strain GAI07411, it will be important to
expand upon this method to make it more accessible and broadly applicable. Having genetically
tractable Prevotella that can be used to show the effectiveness of its various encoded virulence
potential is an important avenue in settling the debate on whether Prevotella plays any significant
role in disease.

4.3 Concluding Remarks
The role of the genus Prevotella in disease is contested due to conflicting associations
with microbiomes despite frequent associations with the microbiomes of chronic inflammatory
diseases. In particular, its ubiquity in CF microbiomes across all ages and stages of disease
poses a further conundrum on its interactions within the CF lung. Phenotypically, there is
evidence that Prevotella might be acting as an accessory pathogen by producing betalactamases that protect Pseudomonas aeruginosa from antimicrobial compounds. Other
Prevotella species show a direct role in pro-inflammatory responses via the recruitment of
neutrophils and the release of Th17 type cytokines. However, it is also found in high relative
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abundance as part of more diverse microbiome environment that is associated with better health
outcomes
There is a growing need for the strain level resolution of microbiomes as more
microbiomes are being characterized and more bacteria important in the polymicrobial style of
pathogenesis of chronic diseases defined by dysbiotic microbiomes are being characterized.
This is especially true for genera such as Prevotella, which can be found in high relative
abundance in both health and disease contexts. The way forward to settling the debate on the
benefits or pathogenesis of Prevotella colonization of the CF lung is via characterization of the
species and the genomes associated with mild or severe CF disease.
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